;doi;Aff1;Country.City;Aff2;Country;Aff3;Country.1;Aff4;Country.2;Aff5;Country.3;Aff6;Country.4;Aff7;Country.5;Aff8;Country.6;Aff9;Country.7;Aff10;Country.8;Aff11;Country.9;Aff12;Country.10;Aff13;Country.11;Aff14;Country.12;Aff15;Country.13;Aff16;Country.14;Aff17;Country.15;Aff18;Country.16;Aff19;Country.17;Aff20;Country.18;Aff21;Country.19;Aff22;Country.20;Aff23;Country.21;Aff24;Country.22;Aff25;Country.23;Aff26;Country.24;Aff27;Country.25;Aff28;Country.26
1;10.1001/jamaophthalmol.2021.6284;CEDARS-SINAI MEDICAL CENTER, LOS ANGELES, CALIFORNIA.;USA;OREGON HEALTH & SCIENCE UNIVERSITY, PORTLAND.;USA;UNIVERSITY OF COLORADO, AURORA.;AURORA;MASSACHUSETTS GENERAL HOSPITAL, HARVARD MEDICAL SCHOOL, BOSTON.;USA;JULES STEIN EYE INSTITUTE, UNIVERSITY OF CALIFORNIA, LOS ANGELES.;USA;EVERSANA, SYDNEY, NOVA SCOTIA, CANADA.;CANADA;EVERSANA, BURLINGTON, ONTARIO, CANADA.;CANADA;EVERSANA, SYDNEY, NOVA SCOTIA, CANADA.;CANADA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
2;10.1002/edm2.259;CARDIFF AND VALE UNIVERSITY CARDIFF UK.;UK;DEPARTMENT OF MEDICINE SOLNA KAROLINSKA INSTITUTET STOCKHOLM SWEDEN.;SWEDEN;NOVO NORDISK A/S SøBORG DENMARK.;DENMARK;PRESENT ADDRESS: NOVO NORDISK NORTH WEST EUROPE PHARMACEUTICALS A/S COPENHAGEN DENMARK.;DENMARK;NOVO NORDISK A/S SøBORG DENMARK.;DENMARK;ZEDEDIAH CONSULTING ON BEHALF OF DRG ABACUS (PART OF CLARIVATE) WOKINGHAM UK.;UK;NOVO NORDISK A/S SøBORG DENMARK.;DENMARK;PRESENT ADDRESS: ONCOPEPTIDES AB LUNTMAKARGATAN 46 STOCKHOLM SWEDEN.;SWEDEN;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
3;10.1007/BF03261873;SHIRE DEVELOPMENT LLC, WAYNE, PA 19087, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
4;10.1007/s00432-021-03602-w;SCHOOL OF MEDICINE, VITA-SALUTE SAN RAFFAELE UNIVERSITY, MILAN;ITALY;UNIT OF ONCOLOGY, UNIVERSITà VITA-SALUTE, IRCCS-SAN RAFFAELE SCIENTIFIC INSTITUTE, VIA OLGETTINA 70, 20132, MILAN, MILANO;ITALY;DEPARTMENT OF BIOMEDICAL SCIENCES, HUMANITAS UNIVERSITY, VIA RITA LEVI MONTALCINI 4, 20090, PIEVE EMANUELE, MILAN, ITALY.;ITALY;MEDICAL ONCOLOGY AND HEMATOLOGY UNIT, HUMANITAS CANCER CENTER, IRCCS HUMANITAS RESEARCH HOSPITAL, VIA MANZONI 56, 20089, ROZZANO, MILAN, ITALY.;ITALY;DEPARTMENT OF ONCOLOGY AND HEMATOLOGY, DIVISION OF ONCOLOGY, UNIVERSITY OF MODENA AND REGGIO EMILIA, 4121, MODENA, ITALY.;ITALY;DEPARTMENT OF ONCOLOGY, ASAN MEDICAL CENTER, UNIVERSITY OF ULSAN COLLEGE OF MEDICINE, SEOUL, KOREA.;KOREA;DEPARTMENT OF ONCOLOGY, ASAN MEDICAL CENTER, UNIVERSITY OF ULSAN COLLEGE OF MEDICINE, SEOUL, KOREA.;KOREA;EARLY PHASE CLINICAL TRIAL UNIT, DEPARTMENT OF ONCOLOGY, VENETO INSTITUTE OF ONCOLOGY IOV-IRCCS, PADUA, ITALY.;ITALY;MEDICAL ONCOLOGY UNIT 1, DEPARTMENT OF ONCOLOGY, VENETO INSTITUTE OF ONCOLOGY IOV - IRCCS, PADUA, ITALY.;ITALY;DEPARTMENT OF TRANSLATIONAL RESEARCH AND NEW TECHNOLOGIES IN MEDICINE AND SURGERY, UNIVERSITY OF PISA, PISA, ITALY.;ITALY;UNIT OF MEDICAL ONCOLOGY 2, AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA, PISA, ITALY.;ITALY;DEPARTMENT OF ONCOLOGY, ASAN MEDICAL CENTER, UNIVERSITY OF ULSAN COLLEGE OF MEDICINE, SEOUL, KOREA.;REPUBLIC OF KOREA;DEPARTMENT OF TRANSLATIONAL RESEARCH AND NEW TECHNOLOGIES IN MEDICINE AND SURGERY, UNIVERSITY OF PISA, PISA, ITALY.;ITALY;UNIT OF MEDICAL ONCOLOGY 2, AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA, PISA, ITALY.;ITALY;DEPARTMENT OF ONCOLOGY, ASAN MEDICAL CENTER, UNIVERSITY OF ULSAN COLLEGE OF MEDICINE, SEOUL, KOREA.;REPUBLIC OF KOREA;MEDICAL ONCOLOGY UNIT 1, DEPARTMENT OF ONCOLOGY, VENETO INSTITUTE OF ONCOLOGY IOV - IRCCS, PADUA, ITALY.;ITALY;DEPARTMENT OF TRANSLATIONAL RESEARCH AND NEW TECHNOLOGIES IN MEDICINE AND SURGERY, UNIVERSITY OF PISA, PISA, ITALY.;ITALY;UNIT OF MEDICAL ONCOLOGY 2, AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA, PISA, ITALY.;ITALY;DEPARTMENT OF ONCOLOGY, ASAN MEDICAL CENTER, UNIVERSITY OF ULSAN COLLEGE OF MEDICINE, SEOUL, KOREA.;KOREA;MEDICAL ONCOLOGY UNIT 1, DEPARTMENT OF ONCOLOGY, VENETO INSTITUTE OF ONCOLOGY IOV - IRCCS, PADUA, ITALY.;ITALY;DEPARTMENT OF SURGERY, ONCOLOGY AND GASTROENTEROLOGY, UNIVERSITY OF PADUA, PADUA, ITALY.;ITALY;DEPARTMENT OF TRANSLATIONAL RESEARCH AND NEW TECHNOLOGIES IN MEDICINE AND SURGERY, UNIVERSITY OF PISA, PISA, ITALY.;ITALY;UNIT OF MEDICAL ONCOLOGY 2, AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA, PISA, ITALY.;ITALY;UNIT OF ONCOLOGY, UNIVERSITà VITA-SALUTE, IRCCS-SAN RAFFAELE SCIENTIFIC INSTITUTE, VIA OLGETTINA 70, 20132, MILAN, MILANO, ITALY.;ITALY;SCHOOL OF MEDICINE, VITA-SALUTE SAN RAFFAELE UNIVERSITY, MILAN, ITALY.;ITALY;UNIT OF ONCOLOGY, UNIVERSITà VITA-SALUTE, IRCCS-SAN RAFFAELE SCIENTIFIC INSTITUTE, VIA OLGETTINA 70, 20132, MILAN, MILANO, ITALY.;ITALY;DEPARTMENT OF MEDICAL AND SURGICAL SCIENCES (DIMEC), UNIVERSITY OF BOLOGNA, BOLOGNA, ITALY.;ITALY;GENERAL AND ONCOLOGIC SURGERY, MORGAGNI-PIERANTONI HOSPITAL, AUSL ROMAGNA, FORLì, ITALY.;ITALY
5;10.1007/s11523-021-00803-8;UNIVERSITà VITA-SALUTE, SAN RAFFAELE HOSPITAL-IRCCS, VIA OLGETTINA 70, 20132, MILANO;ITALY;DEPARTMENT OF MEDICAL ONCOLOGY, SAN RAFFAELE SCIENTIFIC INSTITUTE IRCCS, MILAN;ITALY;DEPARTMENT OF INTERNAL MEDICINE, JAPANESE RED CROSS SOCIETY HIMEJI HOSPITAL, HIMEJI, JAPAN.;JAPAN;DIVISION OF GASTROENTEROLOGY, DEPARTMENT OF MEDICINE, KURUME UNIVERSITY SCHOOL OF MEDICINE, KURUME, FUKUOKA, 830-0011, JAPAN.;JAPAN;FACULTY OF NURSING, GIFU KYORITSU UNIVERSITY, OGAKI, JAPAN.;JAPAN;DIVISION OF GASTROENTEROLOGY, DEPARTMENT OF MEDICINE, KURUME UNIVERSITY SCHOOL OF MEDICINE, KURUME, FUKUOKA, 830-0011, JAPAN.;JAPAN;UNIVERSITà VITA-SALUTE, SAN RAFFAELE HOSPITAL-IRCCS, VIA OLGETTINA 70, 20132, MILANO, ITALY.;ITALY;DEPARTMENT OF MEDICAL ONCOLOGY, SAN RAFFAELE SCIENTIFIC INSTITUTE IRCCS, MILAN, ITALY.;ITALY;DEPARTMENT OF MEDICAL AND SURGICAL SCIENCES, DIMEC, ALMA MATER STUDIORUM-UNIVERSITY OF BOLOGNA, BOLOGNA, ITALY.;ITALY;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
6;10.1007/s12325-014-0167-z;NOVARTIS PHARMA AG, POSTFACH, 4002, BASEL, SWITZERLAND;SWITZERLAND;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
7;10.1007/s12325-017-0564-1;JANSSEN-CILAG, BEERSE;BELGIUM;JANSSEN-CILAG, HIGH WYCOMBE, BUCKINGHAMSHIRE, UK.;UK;JANSSEN-CILAG, BEERSE, BELGIUM.;BELGIUM;JANSSEN-CILAG, HIGH WYCOMBE, BUCKINGHAMSHIRE, UK.;UK;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
8;10.1007/s12325-018-0734-9;ANALYSIS GROUP INC., 111 HUNTINGTON AVE, FLOOR 14, BOSTON, MA, 02199;USA;NOVARTIS PHARMACEUTICALS CORPORATION, 1 HEALTH PLAZA, EAST HANOVER, NJ, 07936, USA.;USA;ANALYSIS GROUP INC., 111 HUNTINGTON AVE, FLOOR 14, BOSTON, MA, 02199, USA.;USA;ANALYSIS GROUP INC., 10 ROCKEFELLER PLAZA, FLOOR 15, NEW YORK, NY, 10020, USA.;USA;NOVARTIS PHARMACEUTICALS CORPORATION, 1 HEALTH PLAZA, EAST HANOVER, NJ, 07936, USA.;USA;ANALYSIS GROUP INC., 10 ROCKEFELLER PLAZA, FLOOR 15, NEW YORK, NY, 10020, USA.;USA;ANALYSIS GROUP INC., 10 ROCKEFELLER PLAZA, FLOOR 15, NEW YORK, NY, 10020, USA.;USA;ANALYSIS GROUP INC., 111 HUNTINGTON AVE, FLOOR 14, BOSTON, MA, 02199, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
9;10.1007/s12325-019-00991-w;EVIDERA, ST-LAURENT, QC;CANADA;PFIZER INC, NEW YORK, NY, USA.;USA;EVIDERA, WALTHAM, MA, USA.;USA;PFIZER INC, CAMBRIDGE, MA, USA.;USA;EVIDERA, ST-LAURENT, QC, CANADA.;CANADA;EVIDERA, WALTHAM, MA, USA.;USA;EVIDERA, ST-LAURENT, QC, CANADA.;CANADA;PFIZER INC, GROTON, CT, USA.;USA;UNIVERSITY HOSPITAL, MüNSTER, GERMANY.;GERMANY;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
10;10.1007/s12325-019-01156-5;DEPARTMENT OF MEDICAL ONCOLOGY, GUY'S, KING'S, AND ST. THOMAS' HOSPITAL, LONDON;UK;EUROPEAN GEORGES POMPIDOU HOSPITAL, PARIS DESCARTES UNIVERSITY, PARIS, FRANCE.;FRANCE;YOKOHAMA CITY UNIVERSITY MEDICAL CENTER, YOKOHAMA, JAPAN.;JAPAN;UNIVERSITY HOSPITALS LEUVEN, LEUVEN, BELGIUM.;BELGIUM;ANALYSIS GROUP, INC, MONTREAL, QC, CANADA.;CANADA;ANALYSIS GROUP, INC, MONTREAL, QC, CANADA.;CANADA;JANSSEN SCIENTIFIC AFFAIRS, HORSHAM, PA, USA.;USA;JANSSEN SCIENTIFIC AFFAIRS, HORSHAM, PA, USA.;USA;JANSSEN GLOBAL SERVICES, RARITAN, NJ, USA.;USA;JANSSEN EMEA, BEERSE, BELGIUM.;BELGUM;JANSSEN EMEA, BEERSE, BELGIUM.;BELGIUM;JANSSEN EMEA, BEERSE, BELGIUM.;BELGIUM;UNIVERSITY OF DUISBURG-ESSEN AND GERMAN CANCER CONSORTIUM (DKTK), PARTNER SITE UNIVERSITY HOSPITAL ESSEN, ESSEN, GERMANY.;GERMANY;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
11;10.1007/s12325-019-01157-4;DEPARTMENT OF MEDICAL ONCOLOGY, GUY'S, KING'S, AND ST. THOMAS' HOSPITAL, LONDON;UK;EUROPEAN GEORGES POMPIDOU HOSPITAL, PARIS DESCARTES UNIVERSITY, PARIS, FRANCE.;FRANCE;YOKOHAMA CITY UNIVERSITY MEDICAL CENTER, YOKOHAMA, JAPAN.;JAPAN;UNIVERSITY HOSPITALS LEUVEN, LEUVEN, BELGIUM.;BELGIUM;ANALYSIS GROUP, INC., MONTRéAL, QC, CANADA.;CANADA;ANALYSIS GROUP, INC., MONTRéAL, QC, CANADA.;CANADA;JANSSEN RESEARCH & DEVELOPMENT, HORSHAM, PA, USA.;USA;JANSSEN RESEARCH & DEVELOPMENT, HORSHAM, PA, USA.;USA;JANSSEN GLOBAL SERVICES, RARITAN, NJ, USA.;USA;JANSSEN EMEA, BEERSE, BELGIUM.;BELGUM;JANSSEN EMEA, BEERSE, BELGIUM.;BELGIUM;JANSSEN EMEA, BEERSE, BELGIUM.;BELGIUM;UNIVERSITY OF DUISBURG-ESSEN AND GERMAN CANCER CONSORTIUM (DKTK), PARTNER SITE UNIVERSITY HOSPITAL ESSEN, ESSEN, GERMANY.;GERMANY;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
12;10.1007/s12325-019-01173-4;ST. LOUIS UNIVERSITY, ST. LOUIS, MO, USA.;USA;LIVERPOOL HEART AND CHEST HOSPITAL, LIVERPOOL, UK.;UK;CARDIOVASCULAR CENTER, OLV HOSPITAL, AALST, BELGIUM.;BELGIUM;CORNERSTONE RESEARCH GROUP INC, SYDNEY, NS, CANADA.;CANADA;CORNERSTONE RESEARCH GROUP INC, BURLINGTON, ON, CANADA.;CANADA;BIOSENSE WEBSTER INC, IRVINE, CA;CA;JOHNSON & JOHNSON MEDICAL S.P.A., POMEZIA, ITALY.;ITALY;JOHNSON & JOHNSON MEDICAL NV, DIEGEM, BELGIUM.;BELGIUM;CORNERSTONE RESEARCH GROUP INC, BURLINGTON, ON, CANADA.;CANADA;CORNERSTONE RESEARCH GROUP INC, BURLINGTON, ON, CANADA.;CANADA;CLINICA MONTEVERGINE MERCOGLIANO (AV), CASA DI CURA SAN MICHELE, MADDALONI, CE, ITALY.;ITALY;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
13;10.1007/s12325-019-0873-7;ANALYSIS GROUP, INC., LOS ANGELES, CA, USA.;USA;AMGEN INC., THOUSAND OAKS, CA, USA.;USA;ANALYSIS GROUP, INC., BOSTON, MA;USA;AMGEN INC., THOUSAND OAKS, CA, USA.;USA;ANALYSIS GROUP, INC., LOS ANGELES, CA, USA.;USA;AMGEN INC., THOUSAND OAKS, CA, USA.;USA;LB BIOSTATISTICS, LONDON, UK.;UK;AMGEN INC., THOUSAND OAKS, CA, USA.;USA;CENTRE FOR HEALTH ECONOMICS, UNIVERSITY OF YORK, YORK, UK.;UK;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
14;10.1007/s12325-020-01298-x;DEPARTMENT OF OPHTHALMOLOGY, SHIGA UNIVERSITY OF MEDICAL SCIENCE, OTSU, JAPAN.;JAPAN;DEPARTMENT OF MEDICINE, UNIVERSITY OF UDINE, UDINE, ITALY.;ITALY;ISPED, CENTRE INSERM U897-EPIDEMIOLOGIE-BIOSTATISTIQUE, UNIVERSITé DE BORDEAUX, BORDEAUX, FRANCE.;FRANCE;INSERM, ISPED, CHU DE BORDEAUX, BORDEAUX, FRANCE.;FRANCE;SERVICE D'OPHTALMOLOGIE, CHU DE BORDEAUX, BORDEAUX, FRANCE.;FRANCE;CREATIV-CEUTICAL, KRAKóW, POLAND.;POLAND;CREATIV-CEUTICAL, LONDON, UK.;UK;BAYER CONSUMER CARE AG, BASEL;SWITZERLAND;BAYER CONSUMER CARE AG, BASEL, SWITZERLAND.;SWITZERLAND;BAYER AG, WUPPERTAL, GERMANY.;GERMANY;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
15;10.1007/s12325-020-01378-y;UCSF, HELEN DILLER FAMILY COMPREHENSIVE CANCER CENTER, SAN FRANCISCO, CA;USA;IPSEN PHARMA, BOULOGNE-BILLANCOURT, FRANCE.;FRANCE;HôPITAL HAUT-LéVêQUE, CHU DE BORDEAUX, BORDEAUX, FRANCE.;FRANCE;AZIENDA OSPEDALIERA G RUMMO, BENEVENTO, ITALY.;ITALY;OSPEDALE DEL MARE, NAPLES, ITALY.;ITALY;UNIVERSITY OF HONG KONG, POKFULAM, HONG KONG.;HONG KONG;NATIONAL TAIWAN UNIVERSITY CANCER CENTER, NATIONAL TAIWAN UNIVERSITY HOSPITAL, TAIPEI, TAIWAN, REPUBLIC OF CHINA.;TAIWAN, REPUBLIC OF CHINA;IPSEN PHARMA, BOULOGNE-BILLANCOURT, FRANCE.;FRANCE;IPSEN PHARMA, BOULOGNE-BILLANCOURT, FRANCE.;France;IQVIA LTD, LONDON, UK.;UK;MEMORIAL SLOAN KETTERING CANCER CENTER, NEW YORK, NY, USA.;USA;WEILL MEDICAL COLLEGE AT CORNELL UNIVERSITY, NEW YORK, NY, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
16;10.1007/s12325-020-01599-1;SOBI, STOCKHOLM;SWEDEN;SOBI, BASEL, SWITZERLAND.;SWITZERLAND;UNIVERSITY OF GRONINGEN, GRONINGEN, THE NETHERLANDS.;THE NETHERLANDS;SOBI, STOCKHOLM, SWEDEN.;SWEDEN;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
17;10.1007/s12325-021-01700-2;GASTROINTESTINAL ONCOLOGY UNIT, MEDICAL CLINIC 1, GOETHE UNIVERSITY HOSPITAL FRANKFURT, THEODOR-STERN-KAI 7, 60590, FRANKFURT;GERMANY;IPSEN PHARMA, BOULOGNE-BILLANCOURT, FRANCE.;FRANCE;ONCOLOGY UNIT, OSPEDALE DEL MARE, NAPLES, ITALY.;ITALY;IPSEN PHARMA, BOULOGNE-BILLANCOURT, FRANCE.;FRANCE;IPSEN PHARMA, BARCELONA, SPAIN.;SPAIN;IQVIA LTD, LONDON, UK.;UK;IQVIA INC, BEIJING, CHINA.;CHINA;DEPARTMENT OF DIGESTIVE DISEASE AND INTERNAL MEDICINE, UNIVERSITY OF BOLOGNA, BOLOGNA, ITALY.;ITALY;DEPARTMENT OF ONCOLOGY, MEDICAL UNIVERSITY OF GDAńSK, GDAńSK, POLAND.;POLAND;COMPREHENSIVE CANCER CENTRE, KING'S COLLEGE LONDON, LONDON, UK.;UK;SAMSUNG MEDICAL CENTER, SUNGKYUNKWAN UNIVERSITY SCHOOL OF MEDICINE, SEOUL, REPUBLIC OF KOREA.;REPUBLIC OF KOREA;DEPARTMENT OF GASTROENTEROLOGY, OTTO VON GUERICKE UNIVERSITY HOSPITAL, MAGDEBURG, GERMANY.;GERMANY;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
18;10.1007/s12325-021-01756-0;LYMPHOMA SERVICE, MEMORIAL SLOAN KETTERING CANCER CENTER, 530 E 74TH ST, NEW YORK, NY, 10021;USA;EVERSANA, SYDNEY, NS, CANADA.;CANADA;BRISTOL MYERS SQUIBB, PRINCETON, NJ, USA.;USA;BRISTOL MYERS SQUIBB, SEATTLE, WA, USA.;USA;BRISTOL MYERS SQUIBB, SEATTLE, WA, USA.;USA;CELGENE, A BRISTOL-MYERS SQUIBB COMPANY, BOUDRY, SWITZERLAND.;SWITZERLAND;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
19;10.1007/s12325-021-01846-z;ST. LOUIS UNIVERSITY, ST. LOUIS, MO, USA.;USA;ANTHEA HOSPITA, BARI, ITALY.;ITALY;CLINICA MONTEVERGINE, MERCOGLIANO, AV, ITALY.;ITALY;CASA DI CURA SAN MICHELE, MADDALONI, CE, ITALY.;ITALY;EVERSANA, BURLINGTON, ON, CANADA.;CANADA;EVERSANA, SYDNEY, NS, CANADA.;CANADA;BIOSENSE WEBSTER INC, IRVINE, CA, USA.;USA;BIOSENSE WEBSTER INC, IRVINE, CA, USA.;USA;JOHNSON & JOHNSON MEDICAL S.P.A, POMEZIA, ITALY.;ITALY;EVERSANA, BURLINGTON, ON;CANADA;LIVERPOOL HEART AND CHEST HOSPITAL, LIVERPOOL, UK.;UK;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
20;10.1007/s12325-021-01853-0;HOSPITAL UNIVERSITARI I POLITèCNIC LA FE, VALENCIA, SPAIN.;SPAIN;HOSPITAL VIRGEN DEL ROCíO, SEVILLE, SPAIN.;SPAIN;HOSPITAL UNIVERSITARI I POLITèCNIC LA FE, VALENCIA, SPAIN.;SPAIN;DR. VON HAUNERSCHES KINDERSPITAL KLINIKUM DER UNIVERSITäT MüNCHEN, MUNICH, GERMANY.;GERMANY;INSTITUTE OF EXPERIMENTAL HAEMATOLOGY AND TRANSFUSION MEDICINE, UNIVERSITY OF BONN, BONN, GERMANY.;GERMANY;EXIGO CONSULTORES, LISBON, PORTUGAL.;PORTUGAL;EXIGO CONSULTORES, LISBON;PORTUGAL;CSL BEHRING, LISBON, PORTUGAL.;PORTUGAL;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
21;10.1007/s12325-021-01884-7;EVIDENCE SYNTHESIS, MODELING, AND COMMUNICATION GROUP, EVIDERA, PARIS, FRANCE.;FRANCE;NIHR/UCLH CLINICAL RESEARCH FACILITY, UNIVERSITY COLLEGE LONDON HOSPITALS, NHS FOUNDATION TRUST, LONDON, UK.;UK;INDIANA UNIVERSITY SIMON CANCER CENTER AND ROUDEBUSH VAMC, INDIANAPOLIS, IN, USA.;USA;EVIDENCE SYNTHESIS, MODELING, AND COMMUNICATION GROUP, EVIDERA, THE ARK, 201 TALGARTH RD, HAMMERSMITH, LONDON, W6 8BJ, UK.;UK;RWE STRATEGY LEAD, VISIBLE ANALYTICS, LONDON, UK.;UK;EVIDENCE SYNTHESIS, MODELING, AND COMMUNICATION GROUP, EVIDERA, SAN FRANCISCO, CA, USA.;USA;VALUE EVIDENCE AND OUTCOMES, GLAXOSMITHKLINE, UPPER PROVIDENCE, PA, USA.;USA;VALUE EVIDENCE AND OUTCOMES, GLAXOSMITHKLINE, UPPER PROVIDENCE, PA, USA.;USA;BRISTOL MYERS SQUIBB, GREATER PHILADELPHIA, PA, USA.;USA;VALUE EVIDENCE AND OUTCOMES, GLAXOSMITHKLINE, UPPER PROVIDENCE, PA, USA.;USA;VALUE EVIDENCE AND OUTCOMES, GLAXOSMITHKLINE, UPPER PROVIDENCE, PA, USA.;USA;VALUE EVIDENCE AND OUTCOMES, GLAXOSMITHKLINE, LONDON, UK.;UK;EVIDENCE SYNTHESIS, MODELING, AND COMMUNICATION GROUP, EVIDERA, THE ARK, 201 TALGARTH RD, HAMMERSMITH, LONDON, W6 8BJ;UK;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
22;10.1007/s12325-021-01885-6;DEPARTMENT OF MEDICAL ONCOLOGY, GUY'S, KING'S, AND ST. THOMAS' HOSPITALS, LONDON;UK;GEORGES POMPIDOU HOSPITAL, UNIVERSITY OF PARIS, PARIS, FRANCE.;FRANCE;YOKOHAMA CITY UNIVERSITY MEDICAL CENTER, YOKOHAMA, JAPAN.;JAPAN;UNIVERSITY HOSPITALS LEUVEN, LEUVEN, BELGIUM.;BELGIUM;JANSSEN GLOBAL SERVICES, RARITAN, NJ, USA.;USA;JANSSEN EMEA, BEERSE, BELGIUM.;BELGIUM;JANSSEN EMEA, BEERSE, BELGIUM.;BELGIUM;JANSSEN EMEA, BEERSE, BELGIUM.;BELGIUM;GERMAN CANCER CONSORTIUM (DKTK), PARTNER SITE UNIVERSITY HOSPITAL ESSEN, UNIVERSITY OF DUISBURG-ESSEN, ESSEN, GERMANY.;GERMANY;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
23;10.1007/s12325-022-02054-z;ANALYSIS GROUP, INC., 1010 EL CAMINO REAL, SUITE 310, MENLO PARK, CA, 94025;USA;ANALYSIS GROUP, INC., 1010 EL CAMINO REAL, SUITE 310, MENLO PARK, CA, 94025, USA.;USA;ANALYSIS GROUP, INC., 1010 EL CAMINO REAL, SUITE 310, MENLO PARK, CA, 94025, USA.;USA;EPIZYME, INC., CAMBRIDGE, MA, 02139, USA.;USA;EPIZYME, INC., CAMBRIDGE, MA, 02139, USA.;USA;EPIZYME, INC., CAMBRIDGE, MA, 02139, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
24;10.1007/s13555-021-00646-1;BRISTOL MEDICAL SCHOOL, UNIVERSITY OF BRISTOL, BRISTOL;UK;CLIFTON INSIGHT, BRISTOL;UK;BRISTOL MEDICAL SCHOOL, UNIVERSITY OF BRISTOL, BRISTOL, UK.;UK;CLIFTON INSIGHT, BRISTOL, UK.;UK;BRISTOL MEDICAL SCHOOL, UNIVERSITY OF BRISTOL, BRISTOL, UK.;UK;CLIFTON INSIGHT, BRISTOL, UK.;UK;PFIZER INC., COLLEGEVILLE, PA, USA.;USA;PFIZER LTD., LONDON, UK.;UK;PFIZER INC., COLLEGEVILLE, PA, USA.;USA;PFIZER INC., GROTON, CT, USA.;USA;PFIZER INC., NEW YORK, NY, USA.;USA;BISPEBJERG HOSPITAL, UNIVERSITY OF COPENHAGEN, COPENHAGEN, UK.;UK;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
25;10.1007/s40258-016-0271-0;PHARMERIT INTERNATIONAL, HEALTH ECONOMICS AND OUTCOMES RESEARCH, MARTEN MEESWEG 107, 3068 AV, ROTTERDAM, THE NETHERLANDS.;THE NETHERLANDS;PHARMERIT INTERNATIONAL, HEALTH ECONOMICS AND OUTCOMES RESEARCH, MARTEN MEESWEG 107, 3068 AV, ROTTERDAM;THE NETHERLANDS;NOVARTIS PHARMACEUTICALS UK, SURREY, UK.;UK;NOVARTIS PHARMACEUTICALS UK, SURREY, UK.;UK;NOVARTIS PHARMACEUTICALS UK, SURREY, UK.;UK;NOVARTIS PHARMACEUTICALS CORPORATION, EAST HANOVER, NJ, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
26;10.1007/s40263-013-0102-x;GLOBAL HEALTH ECONOMICS AND OUTCOMES RESEARCH, SHIRE DEVELOPMENT LLC, 725 CHESTERBROOK BOULEVARD, WAYNE, PA, 19087, USA;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
27;10.1007/s40263-019-00672-w;BRESMED HEALTH SOLUTIONS LTD, SHEFFIELD, UK.;UK;BRESMED HEALTH SOLUTIONS LTD, MANCHESTER, UK.;UK;SAGE THERAPEUTICS, INC., CAMBRIDGE, MA, USA.;USA;BRESMED HEALTH SOLUTIONS LTD, MANCHESTER, UK.;UK;SAGE THERAPEUTICS, INC., CAMBRIDGE, MA;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
28;10.1007/s40263-021-00805-0;PROVIDENCE MULTIPLE SCLEROSIS CENTER, PROVIDENCE BRAIN AND SPINE INSTITUTE, PORTLAND, OR;USA;BRISTOL MYERS SQUIBB, PRINCETON, NJ, USA.;USA;GENESIS RESEARCH, HOBOKEN, NJ, USA.;USA;GENESIS RESEARCH, HOBOKEN, NJ, USA.;USA;GENESIS RESEARCH, HOBOKEN, NJ, USA.;USA;BRISTOL MYERS SQUIBB, PRINCETON, NJ, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
29;10.1007/s40273-021-01015-8;PFIZER INNOVATIONS AB, STOCKHOLM;SWEDEN;, VETENSKAPSVäGEN 10 SE-191 90, SOLLENTUNA;SWEDEN;PFIZER INNOVATIONS AB, STOCKHOLM, SWEDEN.;SWEDEN;PFIZER INC., NEW YORK, NY, USA.;USA;PFIZER INC., NEW YORK, NY, USA.;USA;BRESMED, SHEFFIELD, UK.;UK;BRESMED, SHEFFIELD, UK.;UK;BRESMED, SHEFFIELD, UK.;UK;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
30;10.1007/s40744-017-0070-6;STANFORD UNIVERSITY, PALO ALTO, CA, USA.;USA;ANALYSIS GROUP, INC., LOS ANGELES, CA;USA;ABBVIE INC., NORTH CHICAGO, IL, USA.;USA;ANALYSIS GROUP, INC., LOS ANGELES, CA, USA.;USA;ABBVIE INC., NORTH CHICAGO, IL, USA.;USA;ABBVIE INC., NORTH CHICAGO, IL, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
31;10.1007/s40744-018-0106-6;UNIVERSITY OF QUEENSLAND, BRISBANE, QLD;AUSTRALIA;UNIVERSITY OF GLASGOW, GLASGOW, UK.;UK;SWEDISH MEDICAL CENTER AND UNIVERSITY OF WASHINGTON, SEATTLE, WA, USA.;USA;UNIVERSITY OF BRISTOL, BRISTOL, UK.;UK;MAPI GROUP, MUNICH, GERMANY.;GERMANY;MAPI GROUP, HOUTEN, THE NETHERLANDS.;THE NETHERLANDS;NOVARTIS PHARMACEUTICALS CORPORATION, EAST HANOVER, NJ, USA.;USA;NOVARTIS PHARMA AG, BASEL, SWITZERLAND.;SWITZERLAND;NOVARTIS PHARMA AG, BASEL, SWITZERLAND.;SWITZERLAND;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
32;10.1007/s40744-020-00257-w;NIHR CLINICAL RESEARCH FACILITY, UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST, SOUTHAMPTON, UK.;USA;ABBVIE, INC., NORTH CHICAGO, IL, USA.;USA;ABBVIE, INC., NORTH CHICAGO, IL, USA.;USA;ANALYSIS GROUP, INC., LOS ANGELES, CA, USA.;USA;ABBVIE, INC., NORTH CHICAGO, IL, USA.;USA;ANALYSIS GROUP, INC., LOS ANGELES, CA;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
33;10.1016/j.bbmt.2020.06.008;VANDERBILT-INGRAM CANCER CENTER, NASHVILLE;UK;PRECISION HEOR, OAKLAND, CALIFORNIA.;USA;KITE, A GILEAD COMPANY, SANTA MONICA, CALIFORNIA.;CALIFORNIA;PRECISION HEOR, VANCOUVER, BRITISH COLUMBIA, CANADA.;CANADA;PRECISION HEOR, VANCOUVER, BRITISH COLUMBIA, CANADA.;CANADA;KITE, A GILEAD COMPANY, SANTA MONICA, CALIFORNIA.;USA;MOFFITT CANCER CENTER, TAMPA, FLORIDA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
34;10.1016/j.clgc.2020.07.006;BRESMED HEALTH SOLUTIONS LTD, SHEFFIELD, UK.;UK;BRESMED HEALTH SOLUTIONS LTD, SHEFFIELD, UK.;UK;MERCK & CO, INC, KENILWORTH;KENILWORTH;BRESMED HEALTH SOLUTIONS LTD, SHEFFIELD, UK.;UK;MERCK & CO, INC, KENILWORTH, NJ.;USA;MERCK & CO, INC, KENILWORTH, NJ.;USA;MERCK & CO, INC, KENILWORTH, NJ.;USA;ABRAMSON CANCER CENTER, UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
35;10.1016/j.clinthera.2015.09.013;LASER ANALYTICA, NEW YORK, NEW YORK.;USA;LASER ANALYTICA, NEW YORK, NEW YORK.;USA;CENTRO INTEGRAL ONCOLóGICO CLARA CAMPAL AND START MADRID, MADRID, SPAIN.;SPAIN;NOVARTIS PHARMACEUTICALS CORPORATION, EAST HANOVER, NEW JERSEY.;USA;NOVARTIS PHARMACEUTICALS CORPORATION, EAST HANOVER, NEW JERSEY.;USA;NOVARTIS PHARMACEUTICALS CORPORATION, EAST HANOVER, NEW JERSEY.;USA;NOVARTIS PHARMACEUTICALS CORPORATION, EAST HANOVER, NEW JERSEY.;USA;LASER ANALYTICA, NEW YORK;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
36;10.1016/j.clinthera.2015.12.017;ANALYSIS GROUP, INC., BOSTON;USA;ANALYSIS GROUP, INC., BOSTON, MASSACHUSETTS.;USA;BRISTOL-MYERS SQUIBB, PRINCETON, NEW JERSEY.;USA;BRISTOL-MYERS SQUIBB, PRINCETON, NEW JERSEY.;USA;ANALYSIS GROUP, INC., BOSTON, MASSACHUSETTS.;USA;ANALYSIS GROUP, INC., BOSTON, MASSACHUSETTS.;USA;ANALYSIS GROUP, INC., BOSTON, MASSACHUSETTS.;USA;BRISTOL-MYERS SQUIBB, WALLINGFORD, CONNECTICUT.;USA;ANALYSIS GROUP, INC., BOSTON, MASSACHUSETTS.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
37;10.1016/j.clinthera.2017.08.010;EVIDERA, WALTHAM;USA;CELGENE CORPORATION, SUMMIT, NEW JERSEY.;USA;EVIDERA, WALTHAM, MASSACHUSETTS.;USA;EVIDERA, WALTHAM, MASSACHUSETTS.;USA;CELGENE CORPORATION, SUMMIT, NEW JERSEY.;USA;CELGENE CORPORATION, SUMMIT, NEW JERSEY.;USA;DIVISION OF HEMATOLOGY AND ONCOLOGY, MAYO CLINIC, JACKSONVILLE, FLORIDA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
38;10.1016/j.clinthera.2019.09.012;ASTRAZENECA, GAITHERSBURG, MD;USA;ASTRAZENECA, GAITHERSBURG, MD, UNITED STATES.;USA;ACERTA PHARMA, SAN FRANCISCO, CA, UNITED STATES.;USA;ANALYSIS GROUP, INC., LOS ANGELES, CA, UNITED STATES.;USA;ANALYSIS GROUP, INC., BOSTON, MA, UNITED STATES.;USA;ANALYSIS GROUP, INC., BOSTON, MA, UNITED STATES.;USA;ANALYSIS GROUP, INC., BOSTON, MA, UNITED STATES.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
39;10.1016/j.ejcsup.2021.06.002;CARDIFF & VALE UNIVERSITY HEALTH BOARD, CARDIFF, UK.;UK;PHMR, BERKELEY WORKS, LONDON, UK.;UK;PHMR, BERKELEY WORKS, LONDON, UK.;UK;DEPARTMENT OF NUCLEAR MEDICINE, ERASMUS MEDICAL CENTRE, ROTTERDAM, NETHERLANDS.;THE NETHERLANDS;DEPARTMENT OF NUCLEAR MEDICINE, ERASMUS MEDICAL CENTRE, ROTTERDAM, NETHERLANDS.;THE NETHERLANDS;MEDIZINISCHE KLINIK 1, FRIEDRICH-ALEXANDER-UNIVERSITäT ERLANGEN-NüRNBERG, ERLANGEN, GERMANY.;GERMANY;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
40;10.1016/j.esmoop.2021.100050;DEPARTMENTS OF CUTANEOUS ONCOLOGY AND IMMUNOLOGY, H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, TAMPA;USA;EVIDENCE SYNTHESIS AND DECISION MODELING, PRECISION HEOR, VANCOUVER, CANADA.;CANADA;EVIDENCE SYNTHESIS AND DECISION MODELING, PRECISION HEOR, VANCOUVER, CANADA.;CANADA;MEDICAL ONCOLOGY, BETH ISRAEL DEACONESS MEDICAL CENTER AND HARVARD MEDICAL SCHOOL, BOSTON, USA.;USA;DEPARTMENT OF DERMATOLOGY, ELBE KLINIKEN BUXTEHUDE, BUXTEHUDE, GERMANY.;GERMANY;MEDICAL ONCOLOGY, THE ROYAL MARSDEN HOSPITAL, LONDON, UK.;UK;MEDICAL ONCOLOGY, DANA-FARBER/HARVARD CANCER CENTER, BOSTON, USA.;USA;US HEALTH ECONOMICS AND OUTCOME RESEARCH, METASTATIC MELANOMA, BRISTOL MYERS SQUIBB, PRINCETON, USA.;USA;ONCOLOGY CLINICAL DEVELOPMENT, BRISTOL MYERS SQUIBB, PRINCETON, USA.;USA;WORLDWIDE HEALTH ECONOMICS AND OUTCOMES RESEARCH, MELANOMA, BRISTOL MYERS SQUIBB, UXBRIDGE, UK.;UK;WORLDWIDE HEALTH ECONOMICS AND OUTCOMES RESEARCH, MELANOMA, BRISTOL MYERS SQUIBB, PRINCETON, USA.;USA;US HEALTH ECONOMICS AND OUTCOME RESEARCH, METASTATIC MELANOMA, BRISTOL MYERS SQUIBB, PRINCETON, USA.;USA;WORLDWIDE MEDICAL, MELANOMA, BRISTOL MYERS SQUIBB, PRINCETON, USA.;USA;MEDICAL ONCOLOGY, GEORGETOWN LOMBARDI COMPREHENSIVE CANCER CENTER, WASHINGTON, DC, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;
41;10.1016/j.euo.2018.09.009;BRESMED HEALTH SOLUTIONS, SHEFFIELD, UK.;UK;CENTER FOR OBSERVATIONAL & REAL-WORLD EVIDENCE, MERCK & CO. INC., KENILWORTH, NJ, USA.;USA;CENTER FOR OBSERVATIONAL & REAL-WORLD EVIDENCE, MERCK & CO. INC., KENILWORTH, NJ, USA.;USA;CENTER FOR OBSERVATIONAL & REAL-WORLD EVIDENCE, MERCK & CO. INC., KENILWORTH, NJ, USA.;USA;BRESMED HEALTH SOLUTIONS, SHEFFIELD, UK.;UK;MSD, STOCKHOLM, SWEDEN.;SWEDEN;CENTER FOR OBSERVATIONAL & REAL-WORLD EVIDENCE, MERCK & CO. INC., KENILWORTH, NJ;USA;BRESMED HEALTH SOLUTIONS, SHEFFIELD, UK.;UK;CENTER FOR OBSERVATIONAL & REAL-WORLD EVIDENCE, MERCK & CO. INC., KENILWORTH, NJ, USA.;USA;CENTER FOR OBSERVATIONAL & REAL-WORLD EVIDENCE, MERCK & CO. INC., KENILWORTH, NJ, USA.;USA;DEPARTMENT OF MEDICINE, DIVISION OF ONCOLOGY, UNIVERSITY OF WASHINGTON, FRED HUTCHINSON CANCER RESEARCH CENTER, SEATTLE, WA, USA.;USA;MEDICAL ONCOLOGY, ERASMUS MC CANCER INSTITUTE, ROTTERDAM, THE NETHERLANDS.;THE NETHERLANDS;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
42;10.1016/j.jtho.2016.05.029;DIVISION OF MEDICAL ONCOLOGY, NATIONAL CANCER CENTRE SINGAPORE;SINGAPORE;CENTRAL HOSPITAL OF PORTO, UNIVERSITY OF PORTO, PORTO, PORTUGAL.;PORTUGAL;NOVARTIS PHARMACEUTICALS CORPORATION, EAST HANOVER, NEW JERSEY.;USA;ANALYSIS GROUP, INC., BOSTON, MASSACHUSETTS.;USA;ANALYSIS GROUP, INC., NEW YORK, NEW YORK.;USA;ANALYSIS GROUP, INC., NEW YORK, NEW YORK.;USA;PRINCESS MARGARET CANCER CENTRE, TORONTO, ONTARIO, CANADA.;CANADA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
43;10.1016/j.jval.2018.03.015;COSTELLO MEDICAL CONSULTING LTD., CAMBRIDGE, UNITED KINGDOM.;UK;COSTELLO MEDICAL CONSULTING LTD., CAMBRIDGE, UNITED KINGDOM.;UK;COSTELLO MEDICAL CONSULTING LTD., LONDON, UNITED KINGDOM.;UK;COSTELLO MEDICAL CONSULTING LTD., CAMBRIDGE;UK;COSTELLO MEDICAL CONSULTING LTD., CAMBRIDGE, UNITED KINGDOM.;UK;INSIGHTEC LTD., TIRAT CARMEL, ISRAEL.;ISRAEL;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
44;10.1016/j.jval.2021.03.004;EVIDERA, LONDON;UK;EVIDERA, PARIS, FRANCE.;FRANCE;MERCK KGAA, DARMSTADT, GERMANY.;GERMANY;EVIDERA, MONTREAL, CANADA.;CANADA;EMD SERONO, INC, ROCKLAND, MA, USA, A BUSINESS OF MERCK KGAA, DARMSTADT, GERMANY.;GERMANY;EMD SERONO, INC, ROCKLAND, MA, USA, A BUSINESS OF MERCK KGAA, DARMSTADT, GERMANY.;GERMANY;EMD SERONO, INC, ROCKLAND, MA, USA, A BUSINESS OF MERCK KGAA, DARMSTADT, GERMANY.;GERMANY;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
45;10.1016/j.lungcan.2021.03.020;DEPARTMENT OF ONCOLOGY, MONTEFIORE/ALBERT EINSTEIN CANCER CENTER, 2ND FLOOR, 1695 EASTCHESTER RD, BRONX, NY, 10461;USA;CENTER FOR OBSERVATIONAL & REAL WORLD EVIDENCE (CORE), MERCK & CO., INC., KENILWORTH, NJ, 07033;USA;BIOSTATISTICS AND RESEARCH DECISION SCIENCES, MSD EUROPE, INC., BRUSSELS, 1200;BELGIUM;BIOSTATISTICS AND RESEARCH DECISION SCIENCES, MSD EUROPE, INC., BRUSSELS, 1200;BELGIUM;PRECISIONHEOR, OAKLAND, CA, 94612;USA;ONCOLOGY CLINICAL DEVELOPMENT, MERCK & CO., INC., KENILWORTH, NJ, 07033;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
46;10.1016/j.msard.2021.102972;PROVIDENCE MULTIPLE SCLEROSIS CENTER, PROVIDENCE BRAIN AND SPINE INSTITUTE, 2805 NE GLISAN ST., PORTLAND, OR;USA;BRISTOL MYERS SQUIBB, 3551 LAWRENCEVILLE RD., PRINCETON, NJ, 08540 USA.;USA;GENESIS RESEARCH, 5 MARINE VIEW PLAZA, HOBOKEN, NJ, 07030 USA.;USA;GENESIS RESEARCH, 5 MARINE VIEW PLAZA, HOBOKEN, NJ, 07030 USA.;USA;GENESIS RESEARCH, 5 MARINE VIEW PLAZA, HOBOKEN, NJ, 07030 USA.;USA;BRISTOL MYERS SQUIBB, 3551 LAWRENCEVILLE RD., PRINCETON, NJ, 08540 USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
47;10.1080/03007995.2016.1248380;A MELLEN CENTER FOR MULTIPLE SCLEROSIS TREATMENT AND RESEARCH , CLEVELAND CLINIC , CLEVELAND , OH , USA.;USA;B DEPARTMENT OF NEUROLOGY , UNIVERSITY HOSPITAL BERN AND UNIVERSITY OF BERN , BERN , SWITZERLAND.;SWITZERLAND;C BIOGEN , CAMBRIDGE , MA , USA.;USA;C BIOGEN , CAMBRIDGE , MA , USA.;USA;C BIOGEN , CAMBRIDGE , MA , USA.;USA;C BIOGEN , CAMBRIDGE , MA , USA.;USA;C BIOGEN , CAMBRIDGE , MA , USA.;USA;C BIOGEN , CAMBRIDGE , MA , USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
48;10.1080/03007995.2018.1510225;A BAYLOR UNIVERSITY MEDICAL CENTER , DALLAS , TX , USA.;USA;B ARIAD PHARMACEUTICALS INC., A WHOLLY OWNED SUBSIDIARY OF TAKEDA PHARMACEUTICAL COMPANY LIMITED , CAMBRIDGE , MA , USA.;USA;C CURRENTLY AFFILIATED WITH VERTEX PHARMACEUTICALS INC. , BOSTON , MA , USA.;USA;B ARIAD PHARMACEUTICALS INC., A WHOLLY OWNED SUBSIDIARY OF TAKEDA PHARMACEUTICAL COMPANY LIMITED , CAMBRIDGE , MA , USA.;USA;B ARIAD PHARMACEUTICALS INC., A WHOLLY OWNED SUBSIDIARY OF TAKEDA PHARMACEUTICAL COMPANY LIMITED , CAMBRIDGE , MA , USA.;USA;D INCYTE BIOSCIENCES INTERNATIONAL SàRL , EPALINGES , SWITZERLAND.;SWITZERLAND;E CURRENTLY AFFILIATED WITH PROTHENA SWITZERLAND GMBH , ZUG , SWITZERLAND.;SWITZERLAND;F SIHS HEALTH ECONOMICS CONSULTING , TORINO , ITALY.;ITALY;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
49;10.1080/03007995.2018.1520696;A CITY OF HOPE COMPREHENSIVE CANCER CENTER , DUARTE , CA , USA.;USA;B MILLENNIUM PHARMACEUTICALS, INC., A WHOLLY OWNED SUBSIDIARY OF TAKEDA PHARMACEUTICAL COMPANY LIMITED , CAMBRIDGE , MA , USA.;USA;B MILLENNIUM PHARMACEUTICALS, INC., A WHOLLY OWNED SUBSIDIARY OF TAKEDA PHARMACEUTICAL COMPANY LIMITED , CAMBRIDGE , MA , USA.;USA;C EVIDERA, ST-LAURENT , QUEBEC , CANADA.;CANADA;B MILLENNIUM PHARMACEUTICALS, INC., A WHOLLY OWNED SUBSIDIARY OF TAKEDA PHARMACEUTICAL COMPANY LIMITED , CAMBRIDGE , MA , USA.;USA;C EVIDERA, ST-LAURENT , QUEBEC , CANADA.;CANADA;B MILLENNIUM PHARMACEUTICALS, INC., A WHOLLY OWNED SUBSIDIARY OF TAKEDA PHARMACEUTICAL COMPANY LIMITED , CAMBRIDGE , MA , USA.;USA;B MILLENNIUM PHARMACEUTICALS, INC., A WHOLLY OWNED SUBSIDIARY OF TAKEDA PHARMACEUTICAL COMPANY LIMITED , CAMBRIDGE , MA , USA.;USA;D EVIDERA , SAN FRANCISCO , CA , USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
50;10.1080/03007995.2018.1541443;ANALYSIS GROUP, INC., BOSTON, MA USA.;USA;NOVARTIS PHARMACEUTICALS CORPORATION, EAST HANOVER, NJ, USA.;USA;ANALYSIS GROUP, INC., BOSTON, MA USA.;USA;ANALYSIS GROUP, INC., BOSTON, MA USA.;USA;ANALYSIS GROUP, INC., BOSTON, MA USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
51;10.1080/03007995.2019.1585779;A PAREXEL INTERNATIONAL , LONDON , UK.;UK;B PAREXEL INTERNATIONAL, MOHALI , PUNJAB , INDIA.;INDIA;A PAREXEL INTERNATIONAL , LONDON , UK.;UK;C EMD SERONO RESEARCH AND DEVELOPMENT , BILLERICA , USA.;USA;C EMD SERONO RESEARCH AND DEVELOPMENT , BILLERICA , USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
52;10.1080/03007995.2019.1605239;DEPARTMENT OF LEUKEMIA, MD ANDERSON CANCER CENTER, HOUSTON, TX, USA.;USA;INGRESS-HEALTH, ROTTERDAM, THE NETHERLANDS.;THE NETHERLANDS;PATIENT & HEALTH IMPACT, PFIZER INC., GROTON, CT, USA.;USA;GLOBAL BIOMETRICS & DATA MANAGEMENT, PFIZER INC., GROTON, CT, USA.;USA;WORLDWIDE RESEARCH & DEVELOPMENT, PFIZER INC., WALTON OAKS, UK (AT THE TIME OF THIS RESEARCH).;UK;PATIENT & HEALTH IMPACT, PFIZER INC, NEW YORK, NY, USA (AT THE TIME OF THIS RESEARCH).;USA;DEPARTMENT OF HEMATOLOGY, UNIVERSITY OF MILANO BICOCCA, MONZA, ITALY.;ITALY;INGRESS-HEALTH, ROTTERDAM, THE NETHERLANDS.;THE NETHERLANDS;DEPARTMENT OF ONCOLOGY, JOHN HOPKINS UNIVERSITY SCHOOL OF MEDICINE, BALTIMORE, MD, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
53;10.1080/03007995.2020.1747999;EVERSANA, BURLINGTON, ONTARIO, CANADA.;CANADA;EVERSANA, BURLINGTON, ONTARIO, CANADA.;CANADA;EVERSANA, SYDNEY, NOVA SCOTIA, CANADA.;CANADA;EVERSANA, SYDNEY, NOVA SCOTIA, CANADA.;CANADA;CHARING CROSS HOSPITAL, LONDON, ENGLAND.;ENGLAND;NOVARTIS PHARMA AG, BASEL, SWITZERLAND.;SWITZERLAND;NOVARTIS PHARMA AG, BASEL, SWITZERLAND.;SWITZERLAND;NOVARTIS PHARMA AG, BASEL, SWITZERLAND.;SWITZERLAND;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
54;10.1080/03007995.2021.1896489;INGRESS HEALTH, ROTTERDAM, THE NETHERLANDS.;THE NETHERLANDS;PFIZER INC., GROTON, CT, USA.;USA;PFIZER INC., GROTON, CT, USA.;USA;PFIZER INC., CAMBRIDGE, MA, USA.;USA;PFIZER SLU, MADRID, SPAIN.;SPAIN;INGRESS HEALTH, ROTTERDAM, THE NETHERLANDS.;THE NETHERLANDS;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
55;10.1080/03007995.2021.1947216;NOVARTIS GENE THERAPIES, ZüRICH, SWITZERLAND.;SWITZERLAND;PRECISION HEOR, OAKLAND, CA, UNITED STATES.;USA;DECISION RESOURCES GROUP, MANCHESTER, UNITED KINGDOM.;UK;PHARMALYTICS GROUP, VANCOUVER, BRITISH COLUMBIA, CANADA.;CANADA;PHARMALYTICS GROUP, VANCOUVER, BRITISH COLUMBIA, CANADA.;CANADA;GLOBAL GENECONOMICS AND OUTCOMES RESEARCH, NOVARTIS GENE THERAPIES, INC, BANNOCKBURN, IL, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
56;10.1080/03007995.2021.1953456;UCSF HELEN DILLER FAMILY COMPREHENSIVE CANCER CENTER, SAN FRANCISCO, CA, USA.;USA;LEVINE CANCER INSTITUTE-ATRIUM HEALTH, CHARLOTTE, NC, USA.;USA;JANSSEN R&D, RARITAN, NJ, USA.;USA;JANSSEN GLOBAL SERVICES, LLC, RARITAN, NJ, USA.;USA;JANSSEN R&D, RARITAN, NJ, USA.;USA;JANSSEN R&D, BEERSE, BELGIUM.;BELGIUM;JANSSEN R&D, RARITAN, NJ, USA.;USA;JANSSEN R&D, RARITAN, NJ, USA.;USA;JANSSEN R&D, LOWER GWYNEDD TOWNSHIP, PA, USA.;USA;LEGEND BIOTECH USA, INC, PISCATAWAY, NJ, USA.;USA;LEGEND BIOTECH USA, INC, PISCATAWAY, NJ, USA.;USA;EVERSANA, SYDNEY, NS, CANADA.;CANADA;EVERSANA, SYDNEY, NS, CANADA.;CANADA;JANSSEN R&D, BEERSE, BELGIUM.;BELGIUM;JANSSEN R&D, BEERSE, BELGIUM.;BELGIUM;JANSSEN GLOBAL SERVICES, LLC, RARITAN, NJ, USA.;USA;EVERSANA, BURLINGTON, ON, CANADA.;CANADA;;;;;;;;;;;;;;;;;;;;;;
57;10.1080/03007995.2021.1971182;ANALYSIS GROUP, INC, BOSTON, MA, USA.;USA;APELLIS PHARMACEUTICALS, INC, WALTHAM, MA, USA.;USA;APELLIS PHARMACEUTICALS, INC, WALTHAM, MA, USA.;USA;ANALYSIS GROUP, INC, BOSTON, MA, USA.;USA;ANALYSIS GROUP, INC, BOSTON, MA, USA.;USA;ANALYSIS GROUP, INC, BOSTON, MA, USA.;USA;ANALYSIS GROUP, INC, BOSTON, MA, USA.;USA;ANALYSIS GROUP, INC, BOSTON, MA, USA.;USA;APELLIS PHARMACEUTICALS, INC, WALTHAM, MA, USA.;USA;APELLIS PHARMACEUTICALS, INC, WALTHAM, MA, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
58;10.1080/03007995.2022.2030112;GLOBAL EPIDEMIOLOGY, MERCK HEALTHCARE KGAA, DARMSTADT, GERMANY.;GERMANY;GLOBAL EPIDEMIOLOGY, MERCK HEALTHCARE KGAA, DARMSTADT, GERMANY.;GERMANY;GLOBAL MEDICAL AFFAIRS, MERCK HEALTHCARE KGAA, DARMSTADT, GERMANY.;GERMANY;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
59;10.1080/09546634.2020.1747592;DEPARTMENT OF DERMATOLOGY, ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NEW YORK, NY, USA.;USA;ELI LILLY & COMPANY, INDIANAPOLIS, IN, USA.;USA;ELI LILLY & COMPANY, INDIANAPOLIS, IN, USA.;USA;ELI LILLY & COMPANY, INDIANAPOLIS, IN, USA.;USA;ELI LILLY & COMPANY, INDIANAPOLIS, IN, USA.;USA;DISCIPLINE OF DERMATOLOGY, NORTHERN SYDNEY MEDICAL SCHOOL, UNIVERSITY OF SYDNEY, SYDNEY, NSW, AUSTRALIA.;AUSTRALIA;DEPARTMENT OF DERMATOLOGY, ROYAL NORTH SHORE HOSPITAL, ST LEONARDS, NSW, AUSTRALIA.;AUSTRALIA;DEPARTMENT OF DERMATOLOGY, HADASSAH MEDICAL CENTER, HEBREW UNIVERSITY OF JERUSALEM, THE FACULTY OF MEDICINE, JERUSALEM, ISRAEL.;ISRAEL;INSTITUTE AND COMPREHENSIVE CENTER FOR INFLAMMATION MEDICINE, UNIVERSITY OF LüBECK, LüBECK, GERMANY.;GERMANY;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
60;10.1080/10428194.2019.1648806;DEPARTMENT OF ONCOLOGY AND HEMATOLOGY, UNIVERSITY MEDICAL CENTER OF HAMBURG-EPPENDORF, HAMBURG, GERMANY.;GERMANY;DEPARTMENT OF HEMATOLOGY, ONCOLOGY, IMMUNOLOGY, RHEUMATOLOGY, AND PULMONOLOGY, MEDICAL CLINIC II, TüBINGEN, GERMANY.;GERMANY;AMGEN EUROPE GMBH, ROTKREUZ, SWITZERLAND.;WITZERLAND;AMGEN LTD, UXBRIDGE, UK.;UK;HOSPITAL GERMANS TRIAS I PUJOL, INSTITUT JOSEP CARRERAS, BARCELONA, SPAIN.;SPAIN;INTERNAL MEDICINE V AND NATIONAL CENTER OF TUMOR DISEASES, UNIVERSITY CLINIC HEIDELBERG, HEIDELBERG, GERMANY.;GERMANY;WILHELMINEN CANCER RESEARCH INSTITUTE, WILHELMINENSPITAL, VIENNA, AUSTRIA.;AUSTRIA;AMGEN EUROPE GMBH, ROTKREUZ, SWITZERLAND.;SWITZERLAND;AMGEN EUROPE GMBH, ROTKREUZ, SWITZERLAND.;SWITZERLAND;SCHOOL OF MEDICINE, NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS, ALEXANDRA HOSPITAL, ATHENS, GREECE.;GREECE;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
61;10.1080/10428194.2019.1675881;HAEMATOLOGY DEPARTMENT, UNIVERSITY HOSPITAL OF SALAMANCA/IBSAL, SALAMANCA, SPAIN.;SPAIN;CLíNICA UNIVERSIDAD DE NAVARRA-CIMA, IDISNA, CIBERONC, PAMPLONA, SPAIN.;SPAIN;INTERNAL MEDICINE V AND NATIONAL CENTER OF TUMOR DISEASES (NCT), UNIVERSITY CLINIC HEIDELBERG, HEIDELBERG, GERMANY.;GERMANY;DEPARTMENT OF HAEMATOLOGY, ERASMUS MC, ROTTERDAM, THE NETHERLANDS.;THE NETHERLANDS;DEPARTMENT OF CLINICAL THERAPEUTICS, NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS, ATHENS, GREECE.;GREECE;INGRESS HEALTH, ROTTERDAM, THE NETHERLANDS.;THE NETHERLANDS;INGRESS HEALTH, ROTTERDAM, THE NETHERLANDS.;THE NETHERLANDS;ONCOLOGY R&D, JANSSEN RESEARCH & DEVELOPMENT, BEERSE, BELGIUM.;BELGIUM;STATISTICAL PROGRAMMING (HAEMATOLOGY), JANSSEN RESEARCH & DEVELOPMENT, LLC, RARITAN, NJ, USA.;USA;GLOBAL MARKET ACCESS AND HEALTH POLICY, JANSSEN GLOBAL SERVICES, LLC, RARITAN, NJ, USA.;USA;GLOBAL MARKET ACCESS AND HEALTH POLICY, JANSSEN GLOBAL SERVICES, LLC, RARITAN, NJ, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
62;10.1080/10428194.2019.1682571;DEPARTMENT OF CLINICAL THERAPEUTICS, NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS, ATHENS, GREECE.;GREECE;"DEPARTMENT OF EXPERIMENTAL, DIAGNOSTIC AND SPECIALTY MEDICINE, ""SERAGNOLI"" INSTITUTE OF HEMATOLOGY, UNIVERSITY OF BOLOGNA, BOLOGNA, ITALY.";ITALY;DEPARTMENT OF HEMATOLOGY, UNIVERSITY HOSPITAL OF SALAMANCA/IBSAL, SALAMANCA, SPAIN.;SPAIN;DEPARTMENT OF HEMATOLOGY, UNIVERSITY OF LILLE, CHU LILLE, SERVICE DES MALADIES DU SANG, LILLE, FRANCE.;FRANCE;INGRESS HEALTH, ROTTERDAM, THE NETHERLANDS.;THE NETHERLANDS;INGRESS HEALTH, ROTTERDAM, THE NETHERLANDS.;THE NETHERLANDS;INGRESS HEALTH, ROTTERDAM, THE NETHERLANDS.;THE NETHERLANDS;JANSSEN RESEARCH AND DEVELOPMENT, BEERSE, BELGIUM.;BELGIUM;JANSSEN, EMEA, BEERSE, BELGIUM.;BELGIUM;JANSSEN GLOBAL SERVICES, RARITAN, NJ, USA.;USA;JANSSEN GLOBAL SERVICES, RARITAN, NJ, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
63;10.1080/10428194.2021.1913143;CLíNICA UNIVERSIDAD DE NAVARRA, PAMPLONA, SPAIN.;SPAIN;PRECISIONHEOR, VANCOUVER, BC, CANADA.;CANADA;PRECISIONHEOR, VANCOUVER, BC, CANADA.;CANADA;NYU LANGONE HEALTH, NEW YORK, NY, USA.;USA;DEPARTMENT OF HEMATOLOGY, UNIVERSITY HOSPITAL LEUVEN, LEUVEN, BELGIUM.;BELGIUM;PRECISIONHEOR, VANCOUVER, BC, CANADA.;CANADA;PRECISIONHEOR, VANCOUVER, BC, CANADA.;CANADA;DEPARTMENT OF ONCOLOGY, HEMATOLOGY & BONE MARROW TRANSPLANTATION, UNIVERSITY MEDICAL CENTER OF HAMBURG-EPPENDORF, HAMBURG, GERMANY.;GERMANY;BRISTOL MYERS SQUIBB, PRINCETON, NJ, USA.;USA;CELGENE INTERNATIONAL SàRL, A BRISTOL-MYERS SQUIBB COMPANY, BOUDRY, SWITZERLAND.;SWITZERLAND;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
64;10.1080/10428194.2021.1913144;DEPARTMENT OF MEDICAL ONCOLOGY, DANA-FARBER CANCER INSTITUTE, BOSTON, MA, USA.;USA;ASTRAZENECA, GAITHERSBURG, MD, USA.;USA;ASTRAZENECA, GAITHERSBURG, MD, USA.;USA;ASTRAZENECA, GAITHERSBURG, MD, USA.;USA;DEPARTMENT OF HAEMATOLOGY, UNIVERSITY OF CAMBRIDGE, CAMBRIDGE, UK.;UK;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
65;10.1080/10428194.2021.2010069;LYMPHOMA PROGRAM, ABRAMSON CANCER CENTER, UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PA, USA.;USA;NOVARTIS PHARMACEUTICALS, EAST HANOVER, NJ, USA.;USA;ANALYSIS GROUP, INC., BOSTON, MA, USA.;USA;NOVARTIS PHARMACEUTICALS, EAST HANOVER, NJ, USA.;USA;ANALYSIS GROUP, INC., BOSTON, MA, USA.;USA;NOVARTIS PHARMACEUTICALS, EAST HANOVER, NJ, USA.;USA;NOVARTIS PHARMACEUTICALS, EAST HANOVER, NJ, USA.;USA;NOVARTIS PHARMACEUTICALS, EAST HANOVER, NJ, USA.;USA;KNIGHT CANCER INSTITUTE, OREGON HEALTH AND SCIENCE UNIVERSITY, PORTLAND, OR, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
66;10.1080/10428194.2022.2047962;DEPARTMENT OF ONCOLOGY AND HEMATOLOGY, UNIVERSITY MEDICAL CENTER OF HAMBURG-EPPENDORF, HAMBURG, GERMANY.;GERMANY;DEPARTMENT OF HEMATOLOGY AND MEDICAL ONCOLOGY, WINSHIP CANCER INSTITUTE, EMORY UNIVERSITY, ATLANTA, GA, USA.;USA;DEPARTMENT OF CLINICAL THERAPEUTICS, SCHOOL OF MEDICINE, NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS, ATHENS, GREECE.;GREECE;AUSTRALIAN CENTRE FOR BLOOD DISEASES, MONASH UNIVERSITY, MALIGNANT HAEMATOLOGY & STEM CELL TRANSPLANTATION, ALFRED HOSPITAL AND DEPARTMENT OF CLINICAL HAEMATOLOGY, MONASH UNIVERSITY, MELBOURNE, AUSTRALIA.;AUSTRALIA;INTERNAL MEDICINE V AND NATIONAL CENTER OF TUMOR DISEASES, UNIVERSITY CLINIC HEIDELBERG, HEIDELBERG, GERMANY.;GERMANY;GLOBAL VALUE AND ACCESS, AMGEN GMBH, MUNICH, GERMANY.;GERMANY;GLOBAL BIOSTATISTICAL SCIENCE, AMGEN LTD., UXBRIDGE, UK.;UK;GLOBAL MEDICAL AFFAIRS, AMGEN INC., THOUSAND OAKS, CA, USA.;USA;DEPARTMENT OF INTERNAL MEDICINE, DIVISION OF HEMATOLOGY, MAYO CLINIC ROCHESTER, ROCHESTER, MN, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
67;10.1080/13696998.2018.1443111;A ANALYSIS GROUP, INC. , NEW YORK , NY , USA.;USA;B NOVARTIS PHARMACEUTICALS CORPORATION , EAST HANOVER , NJ , USA.;USA;C ANALYSIS GROUP, INC. , BOSTON , MA , USA.;USA;C ANALYSIS GROUP, INC. , BOSTON , MA , USA.;USA;A ANALYSIS GROUP, INC. , NEW YORK , NY , USA.;USA;A ANALYSIS GROUP, INC. , NEW YORK , NY , USA.;USA;B NOVARTIS PHARMACEUTICALS CORPORATION , EAST HANOVER , NJ , USA.;USA;B NOVARTIS PHARMACEUTICALS CORPORATION , EAST HANOVER , NJ , USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
68;10.1080/13696998.2020.1722139;DERMATOLOGY RESEARCH AND EDUCATION FOUNDATION, IRVINE, CA, USA.;USA;LEO PHARMA, BALLERUP, DENMARK.;DENMARK;LEO PHARMA, MADISON, NJ, USA.;USA;LEO PHARMA, BALLERUP, DENMARK.;DENMARK;LEO PHARMA, MADISON, NJ, USA.;USA;LEO PHARMA, MADISON, NJ, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
69;10.1080/14656566.2020.1811850;DEPARTMENT OF MEDICINE- RHEUMATOLOGY, MOUNT SINAI MEDICAL CENTER , NEW YORK CITY, NY, USA.;USA;ALNYLAM PHARMACEUTICALS , CAMBRIDGE, MA, USA.;USA;ALNYLAM PHARMACEUTICALS , CAMBRIDGE, MA, USA.;USA;ANALYSIS GROUP, INC ., BOSTON, MA, USA.;USA;ANALYSIS GROUP, INC ., BOSTON, MA, USA.;USA;ALNYLAM PHARMACEUTICALS , CAMBRIDGE, MA, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
70;10.1080/14760584.2021.1994858;BIOSTATISTICS AND RESEARCH DECISION SCIENCES, MSD, ZURICH, SWITZERLAND.;SWITZERLAND;BIOSTATISTICS AND RESEARCH DECISION SCIENCES, MSD, ZURICH, SWITZERLAND.;SWITZERLAND;VACCINES, CLINICAL RESEARCH FOR THOMAS WEISS THE AFFILIATION SHOULD READ: CENTER FOR OBSERVATIONAL AND REAL-WORLD EVIDENCE, MERCK & CO., INC, KENILWORTH, NJ, USA.;USA;VACCINES, CLINICAL RESEARCH FOR THOMAS WEISS THE AFFILIATION SHOULD READ: CENTER FOR OBSERVATIONAL AND REAL-WORLD EVIDENCE, MERCK & CO., INC, KENILWORTH, NJ, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
71;10.1080/17474086.2018.1475226;A EVIDENCE SYNTHESIS AND DECISION MODELING , PRECISION XTRACT , VANCOUVER , BC , CANADA.;CANADA;B CENTER FOR OBSERVATIONAL & REAL WORLD EVIDENCE , MERCK & CO, INC , KENILWORTH , NJ , USA.;USA;A EVIDENCE SYNTHESIS AND DECISION MODELING , PRECISION XTRACT , VANCOUVER , BC , CANADA.;CANADA;A EVIDENCE SYNTHESIS AND DECISION MODELING , PRECISION XTRACT , VANCOUVER , BC , CANADA.;CANADA;B CENTER FOR OBSERVATIONAL & REAL WORLD EVIDENCE , MERCK & CO, INC , KENILWORTH , NJ , USA.;USA;B CENTER FOR OBSERVATIONAL & REAL WORLD EVIDENCE , MERCK & CO, INC , KENILWORTH , NJ , USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
72;10.1093/europace/euy160;CARDIOVASCULAR AND CELL SCIENCES RESEARCH INSTITUTE, ST GEORGE'S, UNIVERSITY OF LONDON, LONDON, UK.;UK;DEPARTMENT OF NEUROLOGY AND STROKE CENTRE, PARIS-DIDEROT-SORBONNE UNIVERSITY, PARIS, FRANCE.;FRANCE;FORMERLY INSTITUTE FOR EXPERIMENTAL ONCOLOGY AND THERAPY RESEARCH, TECHNICAL UNIVERSITY OF MUNICH, GERMANY.;GERMANY;MEDICAL AFFAIRS, BAYER AG, BERLIN, GERMANY.;GERMANY;INSTITUTE OF CARDIOVASCULAR SCIENCES, UNIVERSITY OF BIRMINGHAM, UHB AND SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUSTS, BIRMINGHAM, UK.;UK;CHRESTOS CONCEPT GMBH & CO. KG, ESSEN, GERMANY.;GERMANY;MEDICAL AFFAIRS, BAYER AG, BERLIN, GERMANY.;GERMANY;DEPARTMENT OF MEDICINE, MCMASTER UNIVERSITY, HAMILTON, ON, CANADA.;CANADA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
73;10.1093/jnci/djab071;DEPARTMENT OF EPIDEMIOLOGY, JOHNS HOPKINS UNIVERSITY BLOOMBERG SCHOOL OF PUBLIC HEALTH, BALTIMORE, MD, USA.;USA;CENTER FOR DRUG SAFETY AND EFFECTIVENESS, JOHNS HOPKINS UNIVERSITY BLOOMBERG SCHOOL OF PUBLIC HEALTH, BALTIMORE, MD, USA.;USA;THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER, JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE, BALTIMORE, MD, USA.;USA;DEPARTMENT OF BIOSTATISTICS AND BIOINFORMATICS, DUKE UNIVERSITY, DURHAM, NC, USA.;USA;DUKE CLINICAL RESEARCH INSTITUTE, DUKE UNIVERSITY, DURHAM, NC, USA.;USA;WELCH MEDICAL LIBRARY, JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE, BALTIMORE, MD, USA.;USA;THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER, JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE, BALTIMORE, MD, USA.;USA;DEPARTMENT OF EPIDEMIOLOGY, JOHNS HOPKINS UNIVERSITY BLOOMBERG SCHOOL OF PUBLIC HEALTH, BALTIMORE, MD, USA.;USA;THE SIDNEY KIMMEL COMPREHENSIVE CANCER CENTER, JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE, BALTIMORE, MD, USA.;USA;DEPARTMENT OF EPIDEMIOLOGY, JOHNS HOPKINS UNIVERSITY BLOOMBERG SCHOOL OF PUBLIC HEALTH, BALTIMORE, MD, USA.;USA;CENTER FOR DRUG SAFETY AND EFFECTIVENESS, JOHNS HOPKINS UNIVERSITY BLOOMBERG SCHOOL OF PUBLIC HEALTH, BALTIMORE, MD, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
74;10.1097/BRS.0000000000002647;TEXAS BACK INSTITUTE AND THE TEXAS BACK INSTITUTE RESEARCH FOUNDATION, PLANO, TX.;USA;TEXAS BACK INSTITUTE AND THE TEXAS BACK INSTITUTE RESEARCH FOUNDATION, PLANO, TX.;USA;TEXAS BACK INSTITUTE AND THE TEXAS BACK INSTITUTE RESEARCH FOUNDATION, PLANO, TX.;USA;TEXAS BACK INSTITUTE AND THE TEXAS BACK INSTITUTE RESEARCH FOUNDATION, PLANO, TX.;USA;CORNERSTONE RESEARCH GROUP, INC., BURLINGTON, ONTARIO, CANADA.;CANADA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
75;10.1097/COC.0000000000000884;UCSF SCHOOL OF PHARMACY.;USA;UCSF SCHOOL OF PHARMACY.;USA;UCSF SCHOOL OF PHARMACY.;;UCSF SCHOOL OF PHARMACY.;;UCSF SCHOOL OF NURSING, SAN FRANCISCO, CA.;CA;UCSF SCHOOL OF PHARMACY.;;UCSF SCHOOL OF PHARMACY.;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
76;10.1097/JU.0000000000001767;DUKE UNIVERSITY, DURHAM, NORTH CAROLINA.;USA;BAYER, WHIPPANY, NEW JERSEY.;USA;ANALYSIS GROUP, INC., NEW YORK, NEW YORK.;USA;ANALYSIS GROUP, INC., NEW YORK, NEW YORK.;USA;ANALYSIS GROUP, INC., BOSTON, MASSACHUSETTS.;USA;BAYER, WHIPPANY, NEW JERSEY.;USA;CAROLINA UROLOGIC RESEARCH CENTER, MYRTLE BEACH, SOUTH CAROLINA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
77;10.1111/bjd.16140;DERMATOLOGY CENTRE, SALFORD ROYAL NHS FOUNDATION TRUST, THE UNIVERSITY OF MANCHESTER, MANCHESTER ACADEMIC HEALTH SCIENCE CENTRE, NIHR MANCHESTER BIOMEDICAL RESEARCH CENTRE, MANCHESTER, U.K.;UK;ELI LILLY AND COMPANY, LILLY CORPORATE CENTER, INDIANAPOLIS, IN, U.S.A.;USA;ELI LILLY AND COMPANY, LILLY CORPORATE CENTER, INDIANAPOLIS, IN, U.S.A.;USA;DIVISION OF CLINICAL DERMATOLOGY AND CUTANEOUS SCIENCE, DALHOUSIE UNIVERSITY, HALIFAX, NS, CANADA.;CANADA;ELI LILLY AND COMPANY, LILLY CORPORATE CENTER, INDIANAPOLIS, IN, U.S.A.;USA;DEPARTMENT OF DERMATOLOGY, KAISER PERMANENTE LOS ANGELES MEDICAL CENTER, LOS ANGELES, CA, U.S.A.;USA;ELI LILLY AND COMPANY, LILLY CORPORATE CENTER, INDIANAPOLIS, IN, U.S.A.;USA;ELI LILLY AND COMPANY, LILLY CORPORATE CENTER, INDIANAPOLIS, IN, U.S.A.;USA;DIVISION OF EVIDENCE-BASED MEDICINE, DEPARTMENT OF DERMATOLOGY, VENEREOLOGY AND ALLERGOLOGY, CHARITé UNIVERSITäTSMEDIZIN BERLIN, BERLIN, GERMANY.;GERMANY;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
78;10.1111/cea.13561;DEPARTMENT OF RESPIRATORY DISEASES, ARNAUD DE VILLENEUVE HOSPITAL, MONTPELLIER UNIVERSITY HOSPITALS, MONTPELLIER, FRANCE.;FRANCE;INSERM U 1046, ARNAUD DE VILLENEUVE HOSPITAL, UNIVERSITY OF MONTPELLIER, MONTPELLIER, FRANCE.;FRANCE;INSTITUTE OF HEALTH ECONOMICS, EDMONTON, AB, CANADA.;CANADA;DEPARTMENT OF EPIDEMIOLOGY AND COMMUNITY MEDICINE, UNIVERSITY OF OTTAWA, OTTAWA, ON, CANADA.;CANADA;IMAG, CNRS, UNIVERSITY OF MONTPELLIER, CHU MONTPELLIER, MONTPELLIER, FRANCE.;FRANCE;ASTRAZENECA, GOTHENBURG, SWEDEN.;SWEDEN;PAREXEL INTERNATIONAL LTD, CHANDIGARH, INDIA.;INDIA;ASTRAZENECA, BARCELONA, SPAIN.;SPAIN;ASTRAZENECA, GAITHERSBURG, MD, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
79;10.1111/dom.14497;ADVENTHEALTH TRANSLATIONAL RESEARCH INSTITUTE, ORLANDO, FLORIDA, USA.;USA;NOVO NORDISK A/S, SøBORG, DENMARK.;DENMARK;DEPARTMENT OF INTERNAL MEDICINE/ENDOCRINOLOGY, DEPARTMENT OF CLINICAL SCIENCES, UT SOUTHWESTERN MEDICAL CENTER, UNIVERSITY OF TEXAS, DALLAS, TEXAS, USA.;USA;BORTHWICK DIABETES RESEARCH CENTRE, STEVENAGE, UK.;UK;ZEDEDIAH CONSULTING ON BEHALF OF DRG ABACUS (PART OF CLARIVATE), WOKINGHAM, UK.;UK;NOVO NORDISK A/S, SøBORG, DENMARK.;DENMARK;NOVO NORDISK A/S, SøBORG, DENMARK.;DENMARK;NOVO NORDISK A/S, SøBORG, DENMARK.;DENMARK;NOVO NORDISK A/S, SøBORG, DENMARK.;DANEMARK;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
80;10.1111/head.14128;BROADSTREET HEALTH ECONOMICS & OUTCOMES RESEARCH, VANCOUVER, BC, CANADA.;CANADA;BROADSTREET HEALTH ECONOMICS & OUTCOMES RESEARCH, VANCOUVER, BC, CANADA.;CANADA;BIOHAVEN PHARMACEUTICALS, NEW HAVEN, CT, USA.;USA;BIOHAVEN PHARMACEUTICALS, NEW HAVEN, CT, USA.;USA;BIOHAVEN PHARMACEUTICALS, NEW HAVEN, CT, USA.;USA;BROADSTREET HEALTH ECONOMICS & OUTCOMES RESEARCH, VANCOUVER, BC, CANADA.;CANADA;BIOHAVEN PHARMACEUTICALS, NEW HAVEN, CT, USA.;USA;BIOHAVEN PHARMACEUTICALS, NEW HAVEN, CT, USA.;USA;THE HEADACHE CLINIC, ISLAND HOSPITAL, ANACORTES, WA, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
81;10.1111/j.1743-7563.2011.01400.x;TAICHUNG VETERANS GENERAL HOSPITAL, TAICHUNG;TAIWAN;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
82;10.1111/jdv.15369;WHIPPS CROSS UNIVERSITY HOSPITAL & THE ROYAL LONDON HOSPITAL (BARTS HEALTH) NHS TRUST, LONDON, UK.;UK;SUNNYBROOK HEALTH SCIENCES CENTRE, TORONTO, ON, CANADA.;CANADA;DERMATOLOGY DEPARTMENT, UNIVERSITY OF BRESCIA, BRESCIA, ITALY.;ITALY;LEO PHARMA, BALLERUP, DENMARK.;DENMARK;LEO PHARMA, BALLERUP, DENMARK.;DENMARK;ANALYSIS GROUP, BOSTON, MA, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
83;10.1136/rmdopen-2019-001131;SORBONNE UNIVERSITY, PIERRE LOUIS INSTITUTE FOR EPIDEMIOLOGY AND PUBLIC HEALTH;FRANCE; ASSISTANCE PUBLIQUE HOPITAUX DE PARIS, PITIE-SALPETRIERE UNIVERSITY HOSPITAL, RHEUMATOLOGY DEPT, PARIS, FRANCE.;FRANCE;ELI LILLY AND COMPANY, INDIANAPOLIS, INDIANA, USA.;USA;BOTNAR RESEARCH CENTRE, UNIV OF OXFORD, HEADINGTON, UK.;UK;UNIVERSITY OF TWENTE AND ARTHRITIS CENTER TWENTE, ENSCHEDE, NETHERLANDS.;THE NETHERLANDS;LEEDS MSK BIOMED/CHAPEL ALLERTON HOSP, LEEDS, UK.;UK;ELI LILLY AND COMPANY, INDIANAPOLIS, INDIANA, USA.;USA;ELI LILLY AND COMPANY, INDIANAPOLIS, INDIANA, USA.;USA;ELI LILLY AND COMPANY, INDIANAPOLIS, INDIANA, USA.;USA;ELI LILLY AND COMPANY, INDIANAPOLIS, INDIANA, USA.;USA;ELI LILLY AND COMPANY, INDIANAPOLIS, INDIANA, USA.;USA;UNIVERSITY OF TEXAS SOUTHWESTERN MED CTR, DALLAS, TEXAS, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
84;10.1155/2017/6121760;RTI HEALTH SOLUTIONS, 200 PARK OFFICES DR., RESEARCH TRIANGLE PARK, NC, USA.;USA;RTI HEALTH SOLUTIONS, 200 PARK OFFICES DR., RESEARCH TRIANGLE PARK, NC, USA.;USA;RTI HEALTH SOLUTIONS, 200 PARK OFFICES DR., RESEARCH TRIANGLE PARK, NC, USA.;USA;RTI HEALTH SOLUTIONS, 200 PARK OFFICES DR., RESEARCH TRIANGLE PARK, NC, USA.;USA;NOVARTIS PHARMA AG, FORUM 1, NOVARTIS CAMPUS, 4056 BASEL, SWITZERLAND.;SWITZERLAND;NOVARTIS PHARMA AG, FORUM 1, NOVARTIS CAMPUS, 4056 BASEL, SWITZERLAND.;SWITZERLAND;NOVARTIS PHARMA AG, FORUM 1, NOVARTIS CAMPUS, 4056 BASEL, SWITZERLAND.;SWITZERLAND;NOVARTIS PHARMACEUTICALS CORPORATION, ONE HEALTH PLAZA, EAST HANOVER, NJ, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
85;10.1177/1756286420975916;NEUROLOGY AND NEUROSCIENCE INSTITUTE, ALLEGHENY GENERAL HOSPITAL, ALLEGHENY HEALTH NETWORK, PITTSBURGH, PA 15212, USA.;USA;BIOGEN, CAMBRIDGE, MA, USA, AT THE TIME OF THIS ANALYSIS.;USA;BIOGEN, CAMBRIDGE, MA, USA, AT THE TIME OF THIS ANALYSIS.;USA;BIOGEN, CAMBRIDGE, MA, USA.;USA;BIOGEN, CAMBRIDGE, MA, USA.;USA;BIOGEN, CAMBRIDGE, MA, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
86;10.1177/17588359211049639;HEALTH ECONOMICS AND PAYER EVIDENCE, ASTRAZENECA, ACADEMY HOUSE, 136 HILLS ROAD, CAMBRIDGE, CAMBRIDGESHIRE CB2 8PA, UK.;UK;HEALTH ECONOMICS AND PAYER EVIDENCE, ASTRAZENECA, CAMBRIDGE, UK.;UK;CANCER CARE CENTRE, ST GEORGE HOSPITAL, SYDNEY, AUSTRALIA.;AUSTRALIA;GLOBAL MEDICAL AFFAIRS, ASTRAZENECA, CAMBRIDGE, UK.;UK;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
87;10.1183/13993003.01393-2018;DEPT OF RESPIRATORY DISEASES, MONTPELLIER UNIVERSITY HOSPITALS, ARNAUD DE VILLENEUVE HOSPITAL, MONTPELLIER, FRANCE.;FRANCE;INSERM U 1046, UNIVERSITY OF MONTPELLIER, ARNAUD DE VILLENEUVE HOSPITAL, MONTPELLIER, FRANCE.;FRANCE;INSTITUTE OF HEALTH ECONOMICS, EDMONTON, AB, CANADA.;CANADA;DEPT OF EPIDEMIOLOGY AND COMMUNITY MEDICINE, UNIVERSITY OF OTTAWA, OTTAWA, ON, CANADA.;CANADA;IMAG, CNRS, UNIVERSITY OF MONTPELLIER, CHU MONTPELLIER, MONTPELLIER, FRANCE.;FRANCE;ASTRAZENECA, GOTHENBURG, SWEDEN.;SWEDEN;PAREXEL INTERNATIONAL LTD, CHANDIGARH, INDIA.;INDIA;ASTRAZENECA, BARCELONA, SPAIN.;SPAIN;ASTRAZENECA, GAITHERSBURG, MD, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
88;10.1185/03007995.2011.576238;ANALYSIS GROUP , BOSTON, MA 02199;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
89;10.1185/03007995.2014.977992;ANALYSIS GROUP INC. , BOSTON, MA , USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
90;10.1185/03007995.2015.1106934;A A JANSSEN PHARMACEUTICA NV , BEERSE , BELGIUM.;BELGIUM;A A JANSSEN PHARMACEUTICA NV , BEERSE , BELGIUM.;BELGIUM;A A JANSSEN PHARMACEUTICA NV , BEERSE , BELGIUM.;BELGIUM;B B JANSSEN-CILAG GMBH , NEUSS , GERMANY.;GERMANY;C C JB MEDICAL LTD , SUDBURY , UK.;UK;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
91;10.1186/2162-3619-2-32;ANALYSIS GROUP, INC,, 111 HUNTINGTON AVE 10TH FLOOR, BOSTON, MA 02199;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
92;10.1186/s12885-018-5157-0;EVIDERA, 7575 TRANS-CANADA HIGHWAY, SUITE 404, MONTREAL, QUEBEC, H4R 1V6;CANADA;EVIDERA, BUDAPEST, HUNGARY.;HUNGARY;UNIVERSITY OF LYON, CENTRE LéON BéRARD, LYON, FRANCE.;FRANCE;PFIZER INC, NEW YORK, NY, USA.;USA;PFIZER AB, VETENSKAPSVäGEN 10, 191 90, SOLLENTUNA, SWEDEN.;SWEDEN;PFIZER INC, NEW YORK, NY, USA.;USA;PFIZER INC, NEW YORK, NY, USA.;USA;PFIZER INC, NEW YORK, NY, USA.;USA;ROYAL MARSDEN NHS FOUNDATION TRUST, LONDON, UK.;UK;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
93;10.1186/s13045-021-01144-9;FRED HUTCHINSON CANCER RESEARCH CENTER, 1100 FAIRVIEW AVE N, SEATTLE, WA, 98109-1024;USA;PRINCESS MARGARET CANCER CENTRE, TORONTO, ON, CANADA.;CANADA;BRISTOL-MYERS SQUIBB, PRINCETON, NJ, USA.;USA;BRISTOL-MYERS SQUIBB, SEATTLE, WA, USA.;USA;BRISTOL-MYERS SQUIBB, SEATTLE, WA, USA.;USA;EVERSANA, BURLINGTON, ON, CANADA.;CANADA;EVERSANA, BURLINGTON, ON, CANADA.;CANADA;NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST, NOTTINGHAM, UK.;UK;MONTPELLIER UNIVERSITY HOSPITAL CENTER, MONTPELLIER, FRANCE.;FRANCE;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
94;10.1186/s40734-017-0051-5;VANDERBILT UNIVERSITY, 1161 21ST AVENUE SOUTH A-0118, NASHVILLE, TN 37232 USA.;USA;TEVA PHARMACEUTICALS, FRAZER, PA USA.;USA;TEVA PHARMACEUTICALS, LA JOLLA, CA USA.;CA USA;ANALYSIS GROUP, INC., BOSTON, MA USA.;USA;ANALYSIS GROUP, INC., BOSTON, MA USA.;MA USA;TEVA PHARMACEUTICALS, FRAZER, PA USA.;USA;TEVA PHARMACEUTICALS, LA JOLLA, CA USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
95;10.1210/clinem/dgab905;DEPARTMENT OF INTERNAL MEDICINE/ENDOCRINOLOGY, DEPARTMENT OF CLINICAL SCIENCES, UT SOUTHWESTERN MEDICAL CENTER, UNIVERSITY OF TEXAS, DALLAS, TX 75390, USA.;USA;NOVO NORDISK A/S, 2860 SøBORG, DENMARK.;DENMARK;NOVO NORDISK A/S, 2860 SøBORG, DENMARK.;DENMARK;NOVO NORDISK A/S, 2860 SøBORG, DENMARK.;DENMARK;ADVENTHEALTH TRANSLATIONAL RESEARCH INSTITUTE, ORLANDO, FL 32804, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
96;10.1634/theoncologist.2017-0103;JANSSEN HEALTH ECONOMICS & MARKET ACCESS EMEA STATISTICS & MODELING, BEERSE;BELGIUM;JANSSEN HEALTH ECONOMICS & MARKET ACCESS EMEA, HIGH WYCOMBE, UNITED KINGDOM.;UK;JANSSEN HEALTH ECONOMICS & MARKET ACCESS EMEA STATISTICS & MODELING, BEERSE, BELGIUM.;BELGIUM;JANSSEN EMEA MEDICAL AFFAIRS, NEUSS, GERMANY.;GERMANY;DEPARTMENT OF ONCOLOGY, UNIVERSITY OF ALBERTA CROSS CANCER INSTITUTE, EDMONTON, ALBERTA, CANADA.;CANADA;INSTITUT CATALA D'ONCOLOGIA, INSTITUT JOSEP CARRERAS, HOSPITAL GERMANS TRIAS I PUJOL, BARCELONA, SPAIN.;SPAIN;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
97;10.2147/CEOR.S203482;PURPLE SQUIRREL ECONOMICS, NEW YORK, NY, USA.;USA;PURPLE SQUIRREL ECONOMICS, NEW YORK, NY, USA.;USA;PFIZER INC, NEW YORK, NY, USA.;USA;PFIZER INC, NEW YORK, NY, USA.;USA;PFIZER INC, NEW YORK, NY, USA.;USA;PFIZER INC, NEW YORK, NY, USA.;USA;WILLIAM R LINDSAY CHAIR OF HEALTH ECONOMICS, HEALTH ECONOMICS AND TECHNOLOGY ASSESSMENT, INSTITUTE OF HEALTH & WELLBEING, UNIVERSITY OF GLASGOW, GLASGOW, UK.;UK;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
98;10.2147/CMAR.S163478;PURPLE SQUIRREL ECONOMICS, NEW YORK, NY, USA.;USA;NOVARTIS PHARMACEUTICAL CORPORATION, EAST HANOVER, NJ, USA.;USA;PURPLE SQUIRREL ECONOMICS, NEW YORK, NY, USA.;USA;PURPLE SQUIRREL ECONOMICS, NEW YORK, NY, USA.;USA;PURPLE SQUIRREL ECONOMICS, NEW YORK, NY, USA.;USA;NOVARTIS PHARMACEUTICAL CORPORATION, EAST HANOVER, NJ, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
99;10.2147/CMAR.S325043;UNIVERSITY HOSPITAL ERLANGEN, COMPREHENSIVE CANCER CENTER ERLANGEN-EMN, DEPARTMENT OF GYNECOLOGY AND OBSTETRICS, FRIEDRICH-ALEXANDER UNIVERSITY ERLANGEN-NUREMBERG, ERLANGEN, GERMANY.;GERMANY;POLICY ANALYSIS INC. (PAI), BROOKLINE, MA, USA.;USA;NATIONAL TAIWAN UNIVERSITY HOSPITAL, TAIPEI, TAIWAN.;TAIWAN;PETER MACCALLUM CANCER CENTRE, VICTORIA, AUSTRALIA.;AUSTRALIA;UNIVERSITY OF CALIFORNIA, LOS ANGELES, JONSSON COMPREHENSIVE CANCER CENTER, LOS ANGELES, CA, USA.;USA;POLICY ANALYSIS INC. (PAI), BROOKLINE, MA, USA.;USA;NOVARTIS PHARMACEUTICALS CORPORATION, EAST HANOVER, NJ, USA.;USA;NOVARTIS PHARMACEUTICALS CORPORATION, EAST HANOVER, NJ, USA.;USA;NOVARTIS PHARMACEUTICALS CORPORATION, EAST HANOVER, NJ, USA.;USA;NOVARTIS PHARMA AG, BASEL, SWITZERLAND.;SWITZERLAND;DEPARTMENT OF MEDICAL ONCOLOGY, BAYLOR UNIVERSITY MEDICAL CENTER, TEXAS ONCOLOGY AND US ONCOLOGY NETWORK, DALLAS, TX, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
100;10.2147/JBM.S104074;BAYER HEALTHCARE PHARMACEUTICALS, WHIPPANY, NJ.;USA;ANALYSIS GROUP, INC., BOSTON, MA.;USA;ANALYSIS GROUP, INC., BOSTON, MA.;MA;BAYER HEALTHCARE PHARMACEUTICALS, WHIPPANY, NJ.;USA;BAYER HEALTHCARE PHARMACEUTICALS, WHIPPANY, NJ.;USA;ANALYSIS GROUP, INC., BOSTON, MA.;BOSTON;ANALYSIS GROUP, INC., NEW YORK, NY, USA.;USA;ANALYSIS GROUP, INC., BOSTON, MA.;USA;ANALYSIS GROUP, INC., BOSTON, MA.;USA;ANALYSIS GROUP, INC., NEW YORK, NY, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
101;10.2147/JBM.S206806;DEPARTMENT OF INTERNAL MEDICINE, SECTION ON HEMATOLOGY/MEDICAL ONCOLOGY, WAKE FOREST UNIVERSITY BAPTIST MEDICAL CENTER, WINSTON-SALEM, NC, USA.;USA;ANALYSIS GROUP, INC ., BOSTON, MA, USA.;USA;ANALYSIS GROUP, INC ., BOSTON, MA, USA.;USA;GLOBAL MARKET ACCESS HEMATOLOGY, BAYER CONSUMER CARE AG, BASEL, SWITZERLAND.;SWITZERLAND;US DATA GENERATION AND OBSERVATIONAL STUDIES, BAYER CORPORATION, WHIPPANY, NJ, USA.;USA;ANALYSIS GROUP, INC ., BOSTON, MA, USA.;USA;ANALYSIS GROUP, INC ., BOSTON, MA, USA.;USA;GLOBAL MARKET ACCESS HEMATOLOGY, BAYER CONSUMER CARE AG, BASEL, SWITZERLAND.;SWITZERLAND;DEPARTMENT FOR INTERNAL MEDICINE - VASCULAR MEDICINE AND COAGULATION DISORDERS, VIVANTES KLINIKUM IM FRIEDRICHSHAIN, BERLIN, GERMANY.;GERMANY;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
102;10.2147/JBM.S288283;DEPARTMENT OF INTERNAL MEDICINE, HEMOPHILIA TREATMENT CENTRE, VIVANTES KLINIKUM IM FRIEDRICHSHAIN, BERLIN, GERMANY.;GERMANY;CREATIV-CEUTICAL, KRAKOW, POLAND.;POLAND;CREATIV-CEUTICAL, ROTTERDAM, THE NETHERLANDS.;THE NETHERLANDS;CREATIV-CEUTICAL, PARIS, FRANCE.;FRANCE;HEALTH ECONOMICS AND OUTCOMES RESEARCH (GLOBAL), SOBI, STOCKHOLM, SWEDEN.;SWEDEN;HEALTH ECONOMICS AND OUTCOMES RESEARCH (GLOBAL), SOBI, STOCKHOLM, SWEDEN.;SWEDEN;GLOBAL MEDICAL AFFAIRS HEMATOLOGY, SOBI, STOCKHOLM, SWEDEN.;SWEDEN;MEDICAL AND CLINICAL SCIENCES, SOBI, STOCKHOLM, SWEDEN.;SWEDEN;MEDICAL AFFAIRS HEMATOLOGY, SOBI, STOCKHOLM, SWEDEN.;SWEDEN;THE BLEEDING AND CLOTTING DISORDERS INSTITUTE, UNIVERSITY OF ILLINOIS COLLEGE OF MEDICINE-PEORIA, PEORIA, IL, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
103;10.2147/JBM.S312885;DEPARTMENT OF TRANSLATIONAL MEDICINE, LUND UNIVERSITY, AND DEPARTMENT OF HEMATOLOGY, ONCOLOGY AND RADIATION PHYSICS, SKåNE UNIVERSITY HOSPITAL, MALMö, SWEDEN.;SWEDEN;CREATIV-CEUTICAL, KRAKOW, POLAND.;POLAND;CREATIV-CEUTICAL, ROTTERDAM, THE NETHERLANDS.;THE NETHERLANDS;SWEDISH ORPHAN BIOVITRUM AB, STOCKHOLM, SWEDEN.;SWEDEN;SWEDISH ORPHAN BIOVITRUM AB, STOCKHOLM, SWEDEN.;SWEDEN;DEPARTMENT OF INTERNAL MEDICINE, HEMOPHILIA TREATMENT CENTRE, VIVANTES KLINIKUM IM FRIEDRICHSHAIN, BERLIN, GERMANY.;GERMANY;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
104;10.2147/JBM.S321288;US DATA GENERATION AND OBSERVATIONAL STUDIES, BAYER CORPORATION, WHIPPANY, NJ, USA.;USA;DEPARTMENT OF INTERNAL MEDICINE, SECTION ON HEMATOLOGY/MEDICAL ONCOLOGY, WAKE FOREST UNIVERSITY BAPTIST MEDICAL CENTER, WINSTON-SALEM, NC, USA.;USA;DEPARTMENT FOR INTERNAL MEDICINE - VASCULAR MEDICINE AND COAGULATION DISORDERS, VIVANTES KLINIKUM IM FRIEDRICHSHAIN, BERLIN, GERMANY.;GERMANY;CENTER FOR THROMBOSIS AND HEMORRHAGIC DISEASES, IRCCS HUMANITAS RESEARCH HOSPITAL, ROZZANO, MILAN, ITALY.;ITALY;HEOR, CREATIV-CEUTICAL, KRAKOW, POLAND.;POLAND;DEPARTMENT OF EPIDEMIOLOGY, EPIDEMIOLOGY AND PREVENTIVE MEDICINE, JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE, KRAKOW, POLAND.;POLAND;HEMATOLOGY, HEMOSTASIS, ONCOLOGY AND STEM CELL TRANSPLANTATION, HANNOVER MEDICAL SCHOOL, HANNOVER, GERMANY.;GERMANY;CENTER FOR PUBLIC HEALTH RESEARCH, UNIVERSITY OF MILAN - BICOCCA, MONZA, ITALY.;ITALY;VALUE-BASED HEALTHCARE UNIT, IRCCS MULTIMEDICA, SESTO SAN GIOVANNI, ITALY.;ITALY;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
105;10.2147/PTT.S326121;DEPARTMENT OF DERMATOLOGY, THE NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST, NEWCASTLE, UK.;UK;LEO PHARMA A/S, BALLERUP, DENMARK.;DENMARK;LEO PHARMA A/S, BALLERUP, DENMARK.;DENMARK;INSTITUTE FOR HEALTH SERVICES RESEARCH IN DERMATOLOGY AND NURSING (IVDP), UNIVERSITY MEDICAL CENTER HAMBURG-EPPENDORF (UKE), HAMBURG, GERMANY.;GERMANY;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
106;10.2165/11592490-000000000-00000;ANALYSIS GROUP INC., BOSTON, MA 02199;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
107;10.2217/cer.15.33;ANALYSIS GROUP, INC., BOSTON, MA 02199, USA.;USA;ANALYSIS GROUP, INC., BOSTON, MA 02199, USA.;USA;ANALYSIS GROUP, INC., BOSTON, MA 02199, USA.;USA;ANALYSIS GROUP, INC., NEW YORK, NY, USA.;USA;ANALYSIS GROUP, INC., BOSTON, MA 02199, USA.;USA;BRISTOL-MYERS SQUIBB, PRINCETON, NJ, USA.;USA;BRISTOL-MYERS SQUIBB, PRINCETON, NJ, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
108;10.2217/cer.15.49;ANALYSIS GROUP, INC., 111 HUNTINGTON AVENUE, 10TH FLOOR, BOSTON, MA 02199, USA.;USA;ANALYSIS GROUP, INC., 111 HUNTINGTON AVENUE, 10TH FLOOR, BOSTON, MA 02199, USA.;USA;BRISTOL-MYERS SQUIBB, 100 NASSAU PARK BOULEVARD, PRINCETON, NJ 08540, USA.;USA;BRISTOL-MYERS SQUIBB, 100 NASSAU PARK BOULEVARD, PRINCETON, NJ 08540, USA.;USA;ANALYSIS GROUP, INC., 111 HUNTINGTON AVENUE, 10TH FLOOR, BOSTON, MA 02199, USA.;USA;ANALYSIS GROUP, INC., 111 HUNTINGTON AVENUE, 10TH FLOOR, BOSTON, MA 02199, USA.;USA;ANALYSIS GROUP, INC., 111 HUNTINGTON AVENUE, 10TH FLOOR, BOSTON, MA 02199, USA.;USA;BRISTOL-MYERS SQUIBB, 100 NASSAU PARK BOULEVARD, PRINCETON, NJ 08540, USA.;USA;ANALYSIS GROUP, INC., 111 HUNTINGTON AVENUE, 10TH FLOOR, BOSTON, MA 02199, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
109;10.2217/cer.15.69;ANALYSIS GROUP INC., 111 HUNTINGTON AVENUE, 10TH FLOOR, BOSTON, MA 02199, USA.;USA;ANALYSIS GROUP INC., 111 HUNTINGTON AVENUE, 10TH FLOOR, BOSTON, MA 02199, USA.;USA;ANALYSIS GROUP INC., 111 HUNTINGTON AVENUE, 10TH FLOOR, BOSTON, MA 02199, USA.;USA;BRISTOL-MYERS SQUIBB, 100 NASSAU PARK BOULEVARD, PRINCETON, NJ 08540, USA.;USA;BRISTOL-MYERS SQUIBB, 100 NASSAU PARK BOULEVARD, PRINCETON, NJ 08540, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
110;10.2217/cer-2016-0085;BERN UNIVERSITY HOSPITAL, UNIVERSITY OF BERN, BERN, SWITZERLAND.;SWITZERLAND;DEPARTMENT OF NEUROLOGY, UNIVERSITY OF ALABAMA AT BIRMINGHAM, BIRMINGHAM, AL, USA.;USA;MELLEN CENTER FOR MULTIPLE SCLEROSIS, TREATMENT & RESEARCH, DEPARTMENT OF BIOSTATISTICS, CLEVELAND CLINIC, CLEVELAND, OH, USA.;USA;BIOGEN, CAMBRIDGE, MA, USA.;USA;BIOGEN, CAMBRIDGE, MA, USA.;USA;BIOGEN, CAMBRIDGE, MA, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
111;10.2217/cer-2018-0020;EVIDERA, INC., MONTREAL, CANADA.;CANADA;EVIDERA, INC., SAN FRANCISCO, CA 94111, USA.;USA;PFIZER LTD, WALTON OAKS, SURREY, UK.;UK;PFIZER LTD, WALTON OAKS, SURREY, UK.;UK;NORTHERN IRELAND CANCER CENTRE, BELFAST CITY HOSPITAL, BELFAST, UK.;UK;UNIVERSITY OF MANCHESTER INSTITUTE OF CANCER SCIENCES & THE CHRISTIE NHS FOUNDATION TRUST, MANCHESTER, UK.;UK;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
112;10.2217/cer-2018-0141;BIOPHARMACEUTICAL CONSULTANT, 306 RAMONA ROAD, PORTOLA VALLEY, CA 94028, USA.;USA;INSTITUTE OF INFECTION, IMMUNITY & INFLAMMATION, COLLEGE OF MEDICAL, VETERINARY & LIFE SCIENCES, UNIVERSITY OF GLASGOW, SIR GRAEME DAVIES BUILDING, 120 UNIVERSITY PLACE, GLASGOW, G12 8TA, UK.;UK;SWEDISH MEDICAL CENTER & UNIVERSITY OF WASHINGTON, DEPARTMENT OF MEDICINE, 601 BROADWAY, SUITE 600, SEATTLE, WA 98122, USA.;USA;DEPARTMENT OF MEDICINE, UNIVERSITY OF QUEENSLAND, BRISBANE, QLD 4072, AUSTRALIA.;AUSTRALIA;BRISTOL MEDICAL SCHOOL, POPULATION HEALTH SCIENCES, UNIVERSITY OF BRISTOL, CANYNGE HALL, 39 WHATLEY ROAD, BRISTOL, BS8 2PS, UK.;UK;MAPI, AN ICON PLC COMPANY, DE MOLEN 84, 3995 AX, HOUTEN, NETHERLANDS (ADDRESS AT THE TIME THAT THE STUDY WAS CONDUCTED).;THE NETHERLANDS;MAPI, AN ICON PLC COMPANY, KONRAD-ZUSE-PLATZ 11, 81829 MUNICH, GERMANY.;GERMANY;IMMUNOLOGY & DERMATOLOGY FRANCHISE, NOVARTIS PHARMACEUTICALS CORPORATION, ONE HEALTH PLAZA, BUILDING 337, B04.3B, EAST HANOVER, NJ, USA.;USA;IMMUNOLOGY & DERMATOLOGY FRANCHISE, NOVARTIS PHARMACEUTICALS CORPORATION, ONE HEALTH PLAZA, BUILDING 337, B04.3B, EAST HANOVER, NJ, USA.;USA;GLOBAL PATIENT ACCESS IMMUNOLOGY, HEPATOLOGY & DERMATOLOGY, NOVARTIS PHARMA AG, POSTFACH, BASEL, CH-4002, SWITZERLAND.;SWITZERLAND;CREATE CENTRE, SECTION OF RHEUMATOLOGY - DIVISION OF INFECTION & IMMUNITY, CARDIFF UNIVERSITY SCHOOL OF MEDICINE, TENOVUS BUILDING, HEATH PARK CAMPUS, CARDIFF, CF14 4XN, UK.;UK;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
113;10.2217/cer-2019-0145;ROYAL MARSDEN HOSPITAL, LONDON & SURREY, SM2 5PT, UK.;UK;PRECISION XTRACT, VANCOUVER, B.C., V6H 3Y4, CANADA.;CANADA;PRECISION XTRACT, VANCOUVER, B.C., V6H 3Y4, CANADA.;CANADA;PRECISION XTRACT, VANCOUVER, B.C., V6H 3Y4, CANADA.;CANADA;BRISTOL-MYERS SQUIBB, PRINCETON, NJ 08648, USA.;USA;BRISTOL-MYERS SQUIBB, PRINCETON, NJ 08648, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
114;10.2217/cer-2019-0169;ANALYSIS GROUP, INC., 111 HUNTINGTON AVENUE, 14TH FLOOR, BOSTON, MA 02199, USA.;USA;ANALYSIS GROUP, INC., 111 HUNTINGTON AVENUE, 14TH FLOOR, BOSTON, MA 02199, USA.;USA;ANALYSIS GROUP, INC., 111 HUNTINGTON AVENUE, 14TH FLOOR, BOSTON, MA 02199, USA.;USA;US HEOR, BRISTOL-MYERS SQUIBB, 86 MORRIS AVENUE, SUMMIT, NJ 07901, USA.;USA;US HEOR, BRISTOL-MYERS SQUIBB, 86 MORRIS AVENUE, SUMMIT, NJ 07901, USA.;USA;US HEOR, BRISTOL-MYERS SQUIBB, 86 MORRIS AVENUE, SUMMIT, NJ 07901, USA.;USA;US HEOR, BRISTOL-MYERS SQUIBB, 86 MORRIS AVENUE, SUMMIT, NJ 07901, USA.;USA;US HEOR, BRISTOL-MYERS SQUIBB, 86 MORRIS AVENUE, SUMMIT, NJ 07901, USA.;USA;ANALYSIS GROUP, INC., 111 HUNTINGTON AVENUE, 14TH FLOOR, BOSTON, MA 02199, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
115;10.2217/cer-2020-0063;GLOBAL ACCESS, F. HOFFMANN-LA ROCHE LTD, 4070 BASEL, SWITZERLAND.;SWITZERLAND;GLOBAL ACCESS, F. HOFFMANN-LA ROCHE LTD, 4070 BASEL, SWITZERLAND.;SWITZERLAND;HEALTH ECONOMICS & OUTCOMES RESEARCH AND REAL WORLD EVIDENCE, BRESMED LTD, GURUGRAM HARYANA, 122018, INDIA.;INDIA;PRODUCT DEVELOPMENT MEDICAL AFFAIRS, F. HOFFMANN-LA ROCHE LTD, 4070 BASEL, SWITZERLAND.;SWITZERLAND;GLOBAL ACCESS, F. HOFFMANN-LA ROCHE LTD, 4070 BASEL, SWITZERLAND.;SWITZERLAND;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
116;10.2217/cer-2020-0069;NOVARTIS PHARMACEUTICALS CORPORATION, EAST HANOVER, NJ, USA.;USA;NOVARTIS PHARMACEUTICALS CORPORATION, EAST HANOVER, NJ, USA.;USA;EVIDERA, SAN FRANCISCO, CA, USA.;USA;EVIDERA, WALTHAM, MA, USA.;USA;NOVARTIS PHARMACEUTICALS CORPORATION, EAST HANOVER, NJ, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
117;10.2217/cer-2020-0236;DIVISION OF GASTROENTEROLOGY & HEPATOLOGY, UNIVERSITY OF MICHIGAN, ANN ARBOR, MI 48109, USA.;USA;BRISTOL MYERS SQUIBB, PRINCETON, NJ 08540, USA.;USA;ANALYSIS GROUP INC., LOS ANGELES, CA 90071, USA.;USA;ANALYSIS GROUP INC., LOS ANGELES, CA 90071, USA.;USA;ANALYSIS GROUP INC., BOSTON, MA 02199, USA.;USA;ANALYSIS GROUP INC., BOSTON, MA 02199, USA.;USA;ANALYSIS GROUP INC., LOS ANGELES, CA 90071, USA.;USA;BRISTOL MYERS SQUIBB, PRINCETON, NJ 08540, USA.;USA;DEPARTMENT OF GASTROENTEROLOGY ONCOLOGY, MOFFITT CANCER CENTER & RESEARCH INSTITUTE, TAMPA, FL 33612, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
118;10.2217/cer-2020-0272;UNIVERSITY OF CALIFORNIA SAN FRANCISCO COMPREHENSIVE CANCER CENTER, SAN FRANCISCO, CA 94143, USA.;USA;EVERSANA, SYDNEY, NOVA SCOTIA B1P 1C6, CANADA.;CANADA;PFIZER, INC., NY 10017, USA.;USA;EVERSANA, SYDNEY, NOVA SCOTIA B1P 1C6, CANADA.;CANADA;PFIZER, INC., NY 10017, USA.;USA;EVERSANA, SYDNEY, NOVA SCOTIA B1P 1C6, CANADA.;CANADA;PFIZER, INC., NY 10017, USA.;USA;EVERSANA, SYDNEY, NOVA SCOTIA B1P 1C6, CANADA.;CANADA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
119;10.2217/cer-2020-0280;PURPLE SQUIRREL ECONOMICS, MONTREAL H3J 1M1, CANADA.;CANADA;PURPLE SQUIRREL ECONOMICS, MONTREAL H3J 1M1, CANADA.;CANADA;PFIZER INC., NEW YORK, NY 10017, USA.;USA;PFIZER INC., NEW YORK, NY 10017, USA.;USA;PFIZER INC., NEW YORK, NY 10017, USA.;USA;PFIZER INC., NEW YORK, NY 10017, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
120;10.2217/cer-2021-0178;SUNOVION PHARMACEUTICALS INC., MARLBOROUGH, MA 01752, USA.;USA;ANALYSIS GROUP, INC., BOSTON, MA 02199, USA.;USA;ANALYSIS GROUP, INC., BOSTON, MA 02199, USA.;USA;ANALYSIS GROUP, INC., BOSTON, MA 02199, USA.;USA;ANALYSIS GROUP, INC., BOSTON, MA 02199, USA.;USA;SUNOVION PHARMACEUTICALS INC., MARLBOROUGH, MA 01752, USA.;USA;SUNOVION PHARMACEUTICALS INC., MARLBOROUGH, MA 01752, USA.;USA;SUNOVION PHARMACEUTICALS INC., MARLBOROUGH, MA 01752, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
121;10.2217/cer-2021-0216;GLOBAL ACCESS, F. HOFFMANN-LA ROCHE LTD, 4070, BASEL, SWITZERLAND.;SWITZERLAND;GLOBAL ACCESS, F. HOFFMANN-LA ROCHE LTD, 4070, BASEL, SWITZERLAND.;SWITZERLAND;GLOBAL ACCESS, F. HOFFMANN-LA ROCHE LTD, 4070, BASEL, SWITZERLAND.;SWITZERLAND;PDMA NEUROSCIENCE AND RARE DISEASE, F. HOFFMANN-LA ROCHE LTD, 4070, BASEL, SWITZERLAND.;SWITZERLAND;VISIBLE ANALYTICS, OXFORD, OX2 0DP, UK.;UK;VISIBLE ANALYTICS, OXFORD, OX2 0DP, UK.;UK;BRIDGE MEDICAL CONSULTING LTD., RICHMOND, LONDON, TW9 2SS, UK.;UK;VISIBLE ANALYTICS, OXFORD, OX2 0DP, UK.;UK;VISIBLE ANALYTICS, OXFORD, OX2 0DP, UK.;UK;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
122;10.2217/cer-2021-0221;PFIZER, NEW YORK, NY 10017, USA.;USA;EVERSANA, BURLINGTON, ONTARIO, L7N 3H8, CANADA.;CANADA;EVERSANA, SYDNEY, NOVA SCOTIA, B1P 1C6, CANADA.;CANADA;EVERSANA, SYDNEY, NOVA SCOTIA, B1P 1C6, CANADA.;CANADA;EVERSANA, BURLINGTON, ONTARIO, L7N 3H8, CANADA.;CANADA;EVERSANA, SYDNEY, NOVA SCOTIA, B1P 1C6, CANADA.;CANADA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
123;10.2217/fon-2020-0823;PRECISION HEOR, VANCOUVER, BC V6H 3Y4, CANADA.;CANADA;REGENERON PHARMACEUTICALS, INC., TARRYTOWN, NY 10591, USA.;USA;REGENERON PHARMACEUTICALS, INC., TARRYTOWN, NY 10591, USA.;USA;PRECISION HEOR, VANCOUVER, BC V6H 3Y4, CANADA.;CANADA;PRECISION HEOR, VANCOUVER, BC V6H 3Y4, CANADA.;CANADA;REGENERON PHARMACEUTICALS, INC., TARRYTOWN, NY 10591, USA.;USA;SANOFI, READING, RG6 1PT, UK.;UK;PRECISION HEOR, VANCOUVER, BC V6H 3Y4, CANADA.;CANADA;SANOFI, BRIDGEWATER, NJ 08807, USA.;USA;SANOFI, READING, RG6 1PT, UK.;UK;SANOFI, CHILLY-MAZARIN, 91380, FRANCE.;France;PRECISION HEOR, VANCOUVER, BC V6H 3Y4, CANADA.;CANADA;CITY OF HOPE, DUARTE, CA 91010, USA.;USA;REGENERON PHARMACEUTICALS, INC., TARRYTOWN, NY 10591, USA.;USA;REGENERON PHARMACEUTICALS, INC., TARRYTOWN, NY 10591, USA.;USA;SANOFI, BRIDGEWATER, NJ 08807, USA.;USA;DEPARTMENT OF DERMATOLOGY, UNIVERSITY OF BOCHUM, 44801 BOCHUM, GERMANY.;GERMANY;BRISTOL CANCER INSTITUTE, UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST, BRISTOL, BS2 8ED, UK.;UK;BRIGHAM & WOMEN'S/DANA-FARBER CANCER INSTITUTE, HARVARD MEDICAL SCHOOL, BOSTON, MA 02115, USA.;USA;;;;;;;;;;;;;;;;;;
124;10.2217/fon-2021-1509;BRESMED HEALTH SOLUTIONS, MANCHESTER, M2 1DH, UK.;UK;BRESMED HEALTH SOLUTIONS, MANCHESTER, M2 1DH, UK.;UK;BRESMED HEALTH SOLUTIONS, MANCHESTER, M2 1DH, UK.;UK;BLUEPRINT MEDICINES, ZUG, 6300, SWITZERLAND.;SWITZERLAND;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
125;10.2217/imt-2018-0208;GEORGETOWN LOMBARDI COMPREHENSIVE CANCER CENTER, WASHINGTON, DC 20057, USA.;USA;CENTER FOR IMMUNO-ONCOLOGY RESEARCH, CLEVELAND CLINIC, CLEVELAND, OH 44106, USA.;USA;EVIDERA, INC., SAN FRANCISCO, CA 94111, USA.;USA;BRISTOL-MYERS SQUIBB, PRINCETON, NJ 08540, USA.;USA;EVIDERA, INC., SAN FRANCISCO, CA 94111, USA.;USA;BRISTOL-MYERS SQUIBB, PRINCETON, NJ 08540, USA.;USA;BRISTOL-MYERS SQUIBB, PRINCETON, NJ 08540, USA.;USA;BETH ISRAEL DEACONESS MEDICAL CENTER AND HARVARD MEDICAL SCHOOL, BOSTON, MA 02215, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
126;10.2217/imt-2020-0266;SERVICE D'HéMATOLOGIE CLINIQUE, UNIVERSITY HOSPITAL HôTEL-DIEU, NANTES 44000, FRANCE.;FRANCE;INSTITUT UNIVERSITAIRE DU CANCER-ONCOPOLE & CENTRE DE RECHERCHES EN CANCEROLOGIE DE TOULOUSE, TOULOUSE 31100, FRANCE.;FRANCE;UNIVERSITY OF LILLE, CHU LILLE, SERVICE DES MALADIES DU SANG, LILLE 59000, FRANCE.;FRANCE;CHU POITIERS - HôPITAL LA MILéTRIE, POITIERS 86021, FRANCE.;FRANCE;DEPARTMENT OF HEMATOLOGY, HOSPITAL HAUT LEVEQUE, UNIVERSITY HOSPITAL BORDEAUX, BORDEAUX 33600, FRANCE.;FRANCE;INGRESS HEALTH, ROTTERDAM, 3012 NJ, THE NETHERLANDS.;THE NETHERLANDS;INGRESS HEALTH, ROTTERDAM, 3012 NJ, THE NETHERLANDS.;THE NETHERLANDS;HôPITAL DU BOCAGE, CENTRE HOSPITALIER UNIVERSITAIRE DIJON, DIJON 21000, FRANCE.;FRANCE;HôPITAL DE BRETONNEAU, CENTRE HOSPITALIER RéGIONAL UNIVERSITAIRE DE TOURS, TOURS 37000, FRANCE.;FRANCE;DEPARTMENT OF HEMATOLOGY, AMSTERDAM UMC, VRIJE UNIVERSITEIT AMSTERDAM, CANCER CENTER AMSTERDAM, AMSTERDAM 1182 DB, THE NETHERLANDS.;THE NETHERLANDS;UNIVERSITY HOSPITAL HEIDELBERG, INTERNAL MEDICINE V & NATIONAL CENTER FOR TUMOR DISEASES (NCT), HEIDELBERG 69120, GERMANY.;GERMANY;UNIVERSITY MEDICAL CENTER OF HAMBURG-EPPENDORF, HAMBURG 20251, GERMANY.;GERMANY;ASKLEPIOS TUMORZENTRUM HAMBURG, AK ALTONA & AK ST. GEORG, HAMBURG 20099, GERMANY.;GERMANY;DEPARTMENT OF INTERNAL MEDICINE V, UNIVERSITY HOSPITAL HEIDELBERG, HEIDELBERG 69120, GERMANY.;GEMANY;UNIVERSITY HOSPITAL HEIDELBERG, INTERNAL MEDICINE V & NATIONAL CENTER FOR TUMOR DISEASES (NCT), HEIDELBERG 69120, GERMANY.;GERMANY;UNIVERSITY HOSPITAL HEIDELBERG, INTERNAL MEDICINE V & NATIONAL CENTER FOR TUMOR DISEASES (NCT), HEIDELBERG 69120, GERMANY.;GERMANY;JANSSEN RESEARCH & DEVELOPMENT, BEERSE 2340, BELGIUM.;BELGIUM;JANSSEN RESEARCH & DEVELOPMENT, LLC, LEIDEN 2333, THE NETHERLANDS.;THE NETHERLANDS;JANSSEN RESEARCH & DEVELOPMENT, LLC, LEIDEN 2333, THE NETHERLANDS.;THE NETHERLANDS;EVIDERA PPD, MONTREAL, QUEBEC B0E 2K0, CANADA.;CANADA;EVIDERA PPD, MONTREAL, QUEBEC B0E 2K0, CANADA.;CANADA;JANSSEN GLOBAL SERVICES, RARITAN, NJ 08869, USA.;USA;JANSSEN GLOBAL SERVICES, RARITAN, NJ 08869, USA.;USA;JANSSEN GLOBAL SERVICES, RARITAN, NJ 08869, USA.;USA;JANSSEN GLOBAL SERVICES, RARITAN, NJ 08869, USA.;USA;ERASMUS UNIVERSITY MEDICAL CENTER CANCER INSTITUTE, ROTTERDAM 3015 GD, THE NETHERLANDS.;THE NETHERLANDS;;;;
127;10.2217/imt-2021-0273;DEPARTMENT OF ONCOLOGY, MONTEFIORE/ALBERT EINSTEIN CANCER CENTER, 2ND FLOOR, 1695 EASTCHESTER RD, BRONX, NY 10461, USA.;USA;CENTER FOR OBSERVATIONAL & REAL WORLD EVIDENCE, MERCK & CO., INC., KENILWORTH, NJ, USA.;USA;BIOSTATISTICS & RESEARCH DECISION SCIENCES, MSD EUROPE, INC., BRUSSELS, 1200, BELGIUM.;BELGIUM;CENTER FOR OBSERVATIONAL & REAL WORLD EVIDENCE, MERCK & CO., INC., KENILWORTH, NJ, USA.;USA;BIOSTATISTICS & RESEARCH DECISION SCIENCES, MSD EUROPE, INC., BRUSSELS, 1200, BELGIUM.;BELGIUM;PRECISIONHEOR, OAKLAND, CA 94612, USA.;USA;CLINICAL DEVELOPMENT, MERCK & CO., INC., KENILWORTH, NJ, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
128;10.3111/13696998.2013.768530;ANALYSIS GROUP, INC., BOSTON, MA 02199;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
129;10.3390/biom11060780;"DEPARTMENT OF MEDICAL ONCOLOGY, IRCCS ISTITUTO ROMAGNOLO PER LO STUDIO DEI TUMORI ""DINO AMADORI""-IRST, 47014 MELDOLA, ITALY.";ITALY;UNIT OF ONCOLOGY, IRCCS SAN RAFFAELE SCIENTIFIC INSTITUTE, 20132 MILAN, ITALY.;ITALY;SCHOOL OF MEDICINE, VITA-SALUTE SAN RAFFAELE UNIVERSITY, 20132 MILAN, ITALY.;ITALY;DEPARTMENT OF TRANSLATIONAL RESEARCH AND NEW TECHNOLOGIES IN MEDICINE AND SURGERY, UNIVERSITY OF PISA, 56126 PISA, ITALY.;ITALY;UNIT OF MEDICAL ONCOLOGY, AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA, 56126 PISA, ITALY.;ITALY;"DEPARTMENT OF MEDICAL ONCOLOGY, IRCCS ISTITUTO ROMAGNOLO PER LO STUDIO DEI TUMORI ""DINO AMADORI""-IRST, 47014 MELDOLA, ITALY.";ITALY;UNIT OF MEDICAL ONCOLOGY, AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA, 56126 PISA, ITALY.;ITALY;"DEPARTMENT OF MEDICAL ONCOLOGY, IRCCS ISTITUTO ROMAGNOLO PER LO STUDIO DEI TUMORI ""DINO AMADORI""-IRST, 47014 MELDOLA, ITALY.";ITALY;"DEPARTMENT OF MEDICAL ONCOLOGY, IRCCS ISTITUTO ROMAGNOLO PER LO STUDIO DEI TUMORI ""DINO AMADORI""-IRST, 47014 MELDOLA, ITALY.";ITALY;UNIT OF MEDICAL ONCOLOGY, AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA, 56126 PISA, ITALY.;ITALY;DEPARTMENT OF MEDICAL AND SURGICAL SCIENCES (DIMEC), ALMA MATER STUDIORUM-UNIVERSITY OF BOLOGNA, 40126 BOLOGNA, ITALY.;ITALY;DEPARTMENT OF SURGERY, MORGAGNI-PIERANTONI HOSPITAL, AUSL ROMAGNA, 47121 FORLì, ITALY.;ITALY;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
130;10.3390/cancers12123648;DEPARTMENT OF ONCOLOGY, MONTEFIORE/ALBERT EINSTEIN CANCER CENTER, 2ND FLOOR, 1695 EASTCHESTER RD, BRONX, NY 10461, USA.;USA;CENTER FOR OBSERVATIONAL & REAL WORLD EVIDENCE (CORE), MERCK & CO., INC., KENILWORTH, NJ 07033, USA.;USA;BIOSTATISTICS AND RESEARCH DECISION SCIENCES, MSD EUROPE, INC., 1200 BRUSSELS, BELGIUM.;BELGIUM;CENTER FOR OBSERVATIONAL & REAL WORLD EVIDENCE (CORE), MERCK & CO., INC., KENILWORTH, NJ 07033, USA.;USA;BIOSTATISTICS AND RESEARCH DECISION SCIENCES, MSD EUROPE, INC., 1200 BRUSSELS, BELGIUM.;BELGIUM;PRECISION HEOR, OAKLAND, CA 94612, USA.;USA;ONCOLOGY CLINICAL DEVELOPMENT, MERCK & CO., INC., KENILWORTH, NJ 07033, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
131;10.3390/cancers13102406;HEPATOBILIARY SURGERY AND LIVER TRANSPLANTATION UNIT, DEPARTMENT OF SURGICAL, ONCOLOGICAL, AND GASTROENTEROLOGICAL SCIENCES, PADUA UNIVERSITY HOSPITAL, 35128 PADOVA, ITALY.;ITALY;HEPATOBILIARY SURGERY AND LIVER TRANSPLANTATION UNIT, DEPARTMENT OF SURGICAL, ONCOLOGICAL, AND GASTROENTEROLOGICAL SCIENCES, PADUA UNIVERSITY HOSPITAL, 35128 PADOVA, ITALY.;ITALY;HEPATOBILIARY SURGERY AND LIVER TRANSPLANTATION UNIT, DEPARTMENT OF SURGICAL, ONCOLOGICAL, AND GASTROENTEROLOGICAL SCIENCES, PADUA UNIVERSITY HOSPITAL, 35128 PADOVA, ITALY.;ITALY;HEPATOBILIARY SURGERY AND LIVER TRANSPLANTATION UNIT, DEPARTMENT OF SURGICAL, ONCOLOGICAL, AND GASTROENTEROLOGICAL SCIENCES, PADUA UNIVERSITY HOSPITAL, 35128 PADOVA, ITALY.;ITALY;HEPATOBILIARY SURGERY AND LIVER TRANSPLANTATION UNIT, DEPARTMENT OF SURGICAL, ONCOLOGICAL, AND GASTROENTEROLOGICAL SCIENCES, PADUA UNIVERSITY HOSPITAL, 35128 PADOVA, ITALY.;ITALY;HEPATOBILIARY SURGERY AND LIVER TRANSPLANTATION UNIT, DEPARTMENT OF SURGICAL, ONCOLOGICAL, AND GASTROENTEROLOGICAL SCIENCES, PADUA UNIVERSITY HOSPITAL, 35128 PADOVA, ITALY.;ITALY;HEPATOBILIARY SURGERY AND LIVER TRANSPLANTATION UNIT, DEPARTMENT OF SURGICAL, ONCOLOGICAL, AND GASTROENTEROLOGICAL SCIENCES, PADUA UNIVERSITY HOSPITAL, 35128 PADOVA, ITALY.;ITALY;UNIT OF INTERNAL MEDICINE AND HEPATOLOGY, PADUA UNIVERSITY HOSPITAL, 35128 PADOVA, ITALY.;ITALY;MULTIVISCERAL TRANSPLANT UNIT, DEPARTMENT OF SURGERY, ONCOLOGY AND GASTROENTEROLOGY, PADUA UNIVERSITY HOSPITAL, 35128 PADOVA, ITALY.;ITALY;LIVER TRANSPLANTATION PROGRAM, SAPIENZA UNIVERSITY, 00185 ROME, ITALY.;ITALY;HEPATOBILIARY SURGERY AND LIVER TRANSPLANTATION UNIT, DEPARTMENT OF SURGICAL, ONCOLOGICAL, AND GASTROENTEROLOGICAL SCIENCES, PADUA UNIVERSITY HOSPITAL, 35128 PADOVA, ITALY.;ITALY;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
132;10.36469/jheor.2021.19008;PURPLE SQUIRREL ECONOMICS, NEW YORK, NY.;USA;PURPLE SQUIRREL ECONOMICS, NEW YORK, NY.;NY;MESOBLAST INC., NEW YORK, NY.;NY;PURPLE SQUIRREL ECONOMICS, NEW YORK, NY.;NY;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
133;10.5152/eurjrheum.2018.18162;DIVISION OF RHEUMATOLOGY, UNIVERSITY OF ALBERTA SCHOOL OF MEDICINE AND DENTISTRY, EDMONTON, CANADA.;CANADA;DIVISION IMMUNOLOGY-RHEUMATOLOGY, STANFORD UNIVERSITY, PALO ALTO, CALIFORNIA, USA.;USA;DEPARTMENT OF MEDICINE, UNIVERSITY OF QUEENSLAND, BRISBANE, AUSTRALIA.;AUSTRALIA;NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NEW YORK, USA.;USA;UNIVERSITY OF BRISTOL, BRISTOL, UK.;UK;ICON PLC, MUNICH, GERMANY.;GERMANY;ICON PLC, HOUTEN, NETHERLANDS.;THE NETHERLANDS;NOVARTIS PHARMACEUTICALS CORPORATION, EAST HANOVER, NEW JERSEY, USA.;USA;NOVARTIS PHARMACEUTICALS CORPORATION, EAST HANOVER, NEW JERSEY, USA.;USA;NOVARTIS PHARMA AG, BASEL, SWITZERLAND.;SWITZERLAND;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
134;10.5152/eurjrheum.2019.19057;SWEDISH MEDICAL CENTER AND UNIVERSITY OF WASHINGTON, SEATTLE, WA, USA.;USA;CREATE CENTRE, SECTION OF RHEUMATOLOGY, CARDIFF UNIVERSITY SCHOOL OF MEDICINE, CARDIFF, UK.;UK;UNIVERSITY OF QUEENSLAND, BRISBANE, QUEENSLAND, AUSTRALIA.;AUSTRALIA;ICON PLC (FORMERLY MAPI GROUP), HOUTEN, NETHERLANDS.;THE NETHERLANDS;ICON PLC (FORMERLY MAPI GROUP), HOUTEN, NETHERLANDS.;THE NETHERLANDS;ICON PLC (FORMERLY MAPI GROUP), MUNICH, GERMANY.;GERMANY;NOVARTIS PHARMACEUTICALS CORPORATION, EAST HANOVER, NJ, USA.;USA;NOVARTIS PHARMACEUTICALS CORPORATION, EAST HANOVER, NJ, USA.;USA;NOVARTIS PHARMA AG, BASEL, SWITZERLAND.;SWITZERLAND;UNIVERSITY OF BRISTOL, BRISTOL, UK.;UK;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
135;10.1007/s12325-022-02099-0;SIRTEX MEDICAL EUROPE GMBH, JOSEPH-SCHUMPETER-ALLEE 33, 53227, BONN;GERMANY;SIRTEX MEDICAL UNITED KINGDOM LTD., HILL HOUSE, 1 LITTLE NEW STREET, LONDON, EC4A 3TR, UK.;UK;SIRTEX MEDICAL EUROPE GMBH, JOSEPH-SCHUMPETER-ALLEE 33, 53227, BONN, GERMANY.;GERMANY;SIRTEX MEDICAL UNITED KINGDOM LTD., HILL HOUSE, 1 LITTLE NEW STREET, LONDON, EC4A 3TR, UK.;UK;MODULE ÉPIDéMIOLOGIE CLINIQUE, CENTRE D'INVESTIGATION CLINIQUE 1418, INSERM, 75015, PARIS, FRANCE.;FRANCE;ASSISTANCE PUBLIQUE - HôPITAUX DE PARIS, HôPITAL EUROPéEN GEORGES-POMPIDOU, UNITé DE RECHERCHE CLINIQUE, 75015, PARIS, FRANCE.;FRANCE;MODULE ÉPIDéMIOLOGIE CLINIQUE, CENTRE D'INVESTIGATION CLINIQUE 1418, INSERM, 75015, PARIS, FRANCE.;FRANCE;ASSISTANCE PUBLIQUE - HôPITAUX DE PARIS, HôPITAL EUROPéEN GEORGES-POMPIDOU, UNITé DE RECHERCHE CLINIQUE, 75015, PARIS, FRANCE.;FRANCE;CENTRE DE RECHERCHE DE L'INFLAMMATION, INSERM U1149, UNIVERSITé DE PARIS SORBONNE CITé, 75018, PARIS, FRANCE.;FRANCE;ASSISTANCE PUBLIQUE - HôPITAUX DE PARIS, HôPITAUX UNIVERSITAIRES PARIS NORD VAL DE SEINE, HôPITAL BEAUJON, 92118, CLICHY, FRANCE.;FRANCE;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
136;10.2217/fon-2021-1102;CYTEL INC. HEALTH ECONOMICS & OUTCOMES RESEARCH (HEOR). 1050 WINTER ST NO. 2700, WALTHAM, MA 02451, USA.;USA;CYTEL INC. HEALTH ECONOMICS & OUTCOMES RESEARCH (HEOR). 1050 WINTER ST NO. 2700, WALTHAM, MA 02451, USA.;USA;PFIZER INC. HEALTH ECONOMICS & OUTCOMES RESEARCH (HEOR). 235 EAST 42ND STREET NY, NY 10017, USA.;USA;CYTEL INC. HEALTH ECONOMICS & OUTCOMES RESEARCH (HEOR). 1050 WINTER ST NO. 2700, WALTHAM, MA 02451, USA.;USA;PFIZER INC. HEALTH ECONOMICS & OUTCOMES RESEARCH (HEOR). 235 EAST 42ND STREET NY, NY 10017, USA.;USA;PFIZER INC. HEALTH ECONOMICS & OUTCOMES RESEARCH (HEOR). 235 EAST 42ND STREET NY, NY 10017, USA.;USA;PFIZER INC. HEALTH ECONOMICS & OUTCOMES RESEARCH (HEOR). 235 EAST 42ND STREET NY, NY 10017, USA.;USA;PFIZER INC. HEALTH ECONOMICS & OUTCOMES RESEARCH (HEOR). 235 EAST 42ND STREET NY, NY 10017, USA.;USA;PFIZER INC. HEALTH ECONOMICS & OUTCOMES RESEARCH (HEOR). 235 EAST 42ND STREET NY, NY 10017, USA.;USA;UNIVERSITY OF COLORADO CANCER CENTER. THORACIC ONCOLOGY CLINICAL AND CLINICAL RESEARCH PROGRAMS. 1665 AURORA COURT, AURORA, CO 80045, USA.;USA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
137;10.1186/s40164-022-00268-z;Montpellier University Hospital Center, 80 Avenue Augustin Fliche, Montpellier, France;FRANCE;Nottingham University Hospitals NHS Trust, Nottingham, UK.;UK;Bristol Myers Squibb, Princeton, NJ, USA.;USA;Bristol Myers Squibb, Seattle, WA, USA.;USA;Celgene, a Bristol-Myers Squibb Company, Boudry, Switzerland.;SWITZERLAND;Bristol Myers Squibb, Princeton, NJ, USA.;USA;EVERSANA, Burlington, ON, Canada.;CANADA;EVERSANA, Burlington, ON, Canada.;CANADA;Fred Hutchinson Cancer Research Center, Seattle, WA, USA.;USA;Princess Margaret Cancer Centre, Toronto, ON, Canada.;CANADA;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;
